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Cardiac fibrosis (CF) is an integral component of virtually all forms of chronic cardiac disease. CF 
manifests as an accumulation of excessive extracellular matrix (ECM) components throughout the 
myocardium. Aberrant deposition of fibres through the interstitium and perivascular areas have 
structural and functional deleterious consequences for the heart: it stiffens the cardiac muscle and 
causes progressive adverse myocardial remodelling; a pathological hallmark of the failing heart 
irrespective of its etiologic origin. Cells in charge of ECM homeostasis are cardiac fibroblasts, 
which directly contribute to cardiac fibrosis due to their activation and transformation to cardiac 
myofibroblasts upon injury. Cardiac myofibroblasts are therefore key mediators that actively divide 
and produce excessive ECM. Cardiac fibroblasts are a heterogenous population, known to be 
derived from the epicardium and the endocardium in the developing heart. Endothelial-to-
Mesenchymal Transition (EndMT) describes the process of endothelial cell transformation to a 
mesenchymal phenotype, a process that occurs during cardiac development in order to give rise to 
the mesenchymal cells that form the primordia of the valves. In the adult diseased heart, EndMT is 
activated and contributes to the total pool of fibroblasts that are responsible for fibrotic disease. 
Thus, diverse models of murine cardiac fibrosis such as Angiotensin II infusion, aortic banding and 
myocardial infarction (MI) develop fibrosis and exhibit newly activated fibroblasts with endothelial 
origin, as shown by several groups. Injury signals such as hypoxia, TGF-beta and inflammatory 
cytokines are known inducers of in vitro EndMT. Cellular sources of such signals are not well 
characterised.  
Inflammation is another facet of disease that that consistently coexists with fibrosis. Every tissue 
injury triggers an inflammatory response by the innate immune system that aims to heal and re-
establish homeostasis. Macrophages are myeloid cells present at the steady-state heart and are 
highly recruited upon pathological insult. Their specialised functions are critical for the healing 
heart: they phagocyte cardiomyocyte debris and modulate inflammation by secreting inflammatory 
cytokines; but also, they drive inflammation resolution by releasing anti-inflammatory cytokines and 
fibrotic factors. Macrophages are able to display a wide range of features and therefore can be 
subdivided in a spectrum of phenotypes. A simplification of this spectrum relies on two main 
groups, pro-inflammatory macrophages, able to amplify the inflammatory immune response and 
anti-inflammatory macrophages, able to mitigate the inflammatory reaction.
Due to their critical role in both cardiac inflammatory and reparative activities, we hypothesised that 
macrophages had a role in contributing to cardiac EndMT.  Indeed, we identified an increase in 
macrophages in fibrotic regions of human myocardial infarction hearts, aortic stenosis and diabetic 
myocardiopathy. Increased macrophage populations were also identified in murine fibrotic models 
of aortic banding and AngII infusion. Moreover, it was found that macrophages were closely 
associated with endothelial cells undergoing EndMT in a murine model of atherosclerosis. We 
therefore established the tools to investigate a direct link between macrophages and EndMT. We 
generated distinct murine macrophage lines and characterised resident peritoneal macrophages, 
polarised bone marrow-derived macrophages  and the polarised RAW264.7 macrophage cell line. 
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Three different in vitro cell culture systems were then established to analyse unidirectional 
paracrine signalling, bidirectional paracrine signalling, and juxtacrine signalling between endothelial 
cells and macrophages. As a control, EndMT was induced in mouse cardiac endothelial cells with 
TGF-Beta and inflammatory cytokines. These results demonstrated that indeed macrophages 
alone induce EndMT via a juxtacrine cell-cell contact manner but not under paracrine conditions. 
Interestingly, we found that pro-inflammatory TLR-stimulated bone marrow-derived macrophages 
showed enhanced induction of EndMT compared with anti-inflammatory bone marrow-derived 
macrophages. Moreover, pro-inflammatory TLR-stimulated RAW 264.7 cells, but neither native nor 
anti-inflammatory RAW 264.7 cells, induced EndMT. We additionally found that pro-inflammatory 
RAW 264.7 cells induced-EndMT and were associated with induction of the Notch signalling 
pathway; a juxtacrine signalling pathway known to induce EndMT during embryonic development.
Next the vice versa impact of EndMT on macrophage polarisation phenotype was investigated. We 
found that EndMT cells hindered the macrophage activation phenotype by down-regulation of pro-
inflammatory markers TNF-alpha, MHCII and CCL2 in a paracrine related manner. EndMT also 
inhibited anti-inflammatory and pro-fibrotic macrophage markers.
In summary, this PhD thesis describes the crosstalk between macrophages and cardiac endothelial 
cells undergoing EndMT.
Zusammenfassung 
Die kardiale Fibrose ist eine zentrale Komponente nahezu aller chronischer Herzerkrankungen. 
Diese manifestiert sich als eine Akkumulation von Extrazellulärmatrix im Myokard. Diese 
Deposition extrazellulärer Matrix im Interstitium und perivaskulären Arealen hat ungünstige 
Konsequenzen für das Herz: es versteift den Herzmuskel und verursacht ein progressives 
myokardiales Remodelling als wichtiges Phänomen des Herzversagens unabhängig von dessen 
Ursache. Extrazellulärmatrix wird hierbei insbesondere von kardialen Fibroblasten gebildet, 
welches direkt zur kardialen Fibrose durch deren Aktivierung und Transdifferenzierung zu 
Myofibroblasten beiträgt. Diese kardialen Myofibroblasten nehmen somit eine Schlüsselrolle bei 
Herzfibrose ein und sind durch vermehrte proliferative Aktivität charakterisiert. Kardiale 
Fibroblasten sind eine heterogene Population, welche in der Herzentwicklung vom Epikard und 
Endokard abstammen. Die sog. endothelial-mesenchymale Transition (EndMT) beschreibt hierbei 
einen Prozess der Transdifferenzierung von endothelialen Zellen hin zu Zellen mit 
mesenchymalem Phänotyp, ein Prozess der in der Herzentwicklung mesenchymale Zellen zur 
Anlage der Herzklappen generiert. Im adulten Herzen spielt EndMT bei Herzerkrankungen ein 
Rolle und trägt durch dessen Aktivierung zum Fibroblastenpool und Fibrose bei. Somit kann eine 
Aktivierung von EndMT in multiplen murinen Modellen der Herzfibrose wie Angiotensin II-Infusion, 
Aortenstenose und myokardialer Ischämie beobachtet werden und produziert neue aktivierte 
Myofibroblasten mit endothelialem Ursprung, wie von zahlreichen Arbeitsgruppen gezeigt werden 
konnte. Stimuli wie Hypoxie, TGF-beta und inflammatorische Zytokine, welche im kranken Herzen 
induziert werden, sind bekannte Mediatoren von EndMT in vitro. Dagegen sind die zellulären 
Ursachen solcher Stimuli nur wenig charakterisiert. 
Eine weitere Komponente von Fibrose ist die assoziierte Inflammation. Jeder Organschaden 
vermittelt eine inflammatorische Antwort des Immunsystems, um Heilung zu vermitteln und 
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Homöostase wiederherzustellen. Makrophagen sind Zellen myeloischen Ursprungs, welche im 
Herzen präsent sind und bei pathologischen Insulten vermehrt rekrutiert werden. Deren 
spezialisierte Funktionen sind kritische Komponenten für Heilungsprozesse im Herzen: diese 
phagozytieren Zellschrott und modulieren die inflammatorische Antwort durch Sekretion von 
Zytokinen; Makrophagen können aber auch Inflammation durch anti-inflammatorische und 
fibrotische Wachstumsfaktoren auflösen. Aufgrund der zahlreichen Funktionen von Makrophagen 
lassen sich diese in Subtypen unterteilen. Eine einfache Unterteilung ist hierbei die Trennung in die 
beiden Hauptgruppen "M1" als pro-inflammatorische und "M2" als anti-inflammatorische 
Makrophagen.
Aufgrund derer kritischen Funktionen bei sowohl Inflammation und Reparaturprozessen 
vermuteten wir, dass Makrophagen eine Rolle auch bei EndMT im Herzen spielen könnten. Wir 
konnten zeigen, dass Makrophagen in fibrotischen Arealen humaner Herzen nach myokardialer 
Ischämie, bei Aortenstenose und diabetischer Kardiomyopathie akkumulieren. Dies konnte in den 
Mausmodellen der Aortenstenose und der Angiotensin II-Infusion bestätigt werden. Zudem konnten 
wir etablieren, dass Makrophagen mit EndMT Zellen räumlich assoziiert sind. Um einen direkten 
Zusammenhang zwischen Makrophagen und EndMT zu etablieren, generierten wir murine 
Makrophagenzelllinien, charakterisierten residente Peritonealmakrophagen und polarisierten 
Makrophagen aus dem Knochenmark bzw. die Makrophagen Zelllinie RAW264.7. Zudem 
etablierten wir 3 in vitro Zellkultursysteme, um unidirektionale bzw. bidirektionale parakrine sowie 
juxtakrine Effekte zwischen endothelialen Zellen und Makrophagen zu untersuchen. Als Kontrolle 
wurde EndMT in murinen kardialen Endothelzellen mit TGF-beta und inflammatorischen Zytokinen 
induziert. Wir konnten zeigen, dass Makrophagen tatsächlich EndMT in Endothelzellen durch 
juxtakrine Zellinteraktion vermitteln können, allerdings nicht unter parakrinen Konditionen. 
Interessanterweise konnten wir zudem etablieren, dass pro-inflammatorische Makrophagen aus 
dem Knochenmark verglichen mit nativen und anti-inflammatorischen Makrophagen aus dem 
Knochenmark nach TLR-Stimulation vermehrt EndMT induzieren. Dies konnte auch für pro-
inflammatorische RAW264.7-Zellen gezeigt werden. Zudem war EndMT durch inflammatorische 
RAW264.7-Zellen mit einer Induktion der Notch-Signalkaskade, die auch in EndMT-Induktion in der 
Embryonalentwicklung involviert ist, assoziiert. Umgekehrt konnte gezeigt werden, dass EndMT-
Zellen die Aktivierung von Makrophagen durch Repression der pro-inflammatorischen Marker TNF-
alpha, MHCII und CCL2 in parakriner Weise hemmen. Zudem hemmte EndMT auch anti-
inflammatorische und pro-fibrotische Marker in Makrophagen. 
Zusammenfassend beschreibt diese PhD-Arbeit die Wechselwirkung zwischen Makrophagen und 
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Fibrosis appears in the body as a chronic signature of major organ diseases that worsens with age 
(1-3). In the heart, cardiac fibrosis (CF) is an integral component of virtually all forms of chronic 
heart disease and it is characterised by an excess of extracellular matrix (ECM) deposition in the 
cardiac interstitium, generated by fibroblasts (4). ECM in the heart is the structural protein network 
between cardiomyocytes. It is composed of a majority of fibrillar collagen I, which confers tensile 
strength, and collagen III, which confers relative elasticity (4,5). Cardiac ECM fundamentally 
provides structural support, aligning cardiac myofibrils in a laminar structure that prevents them 
from detrimental sarcomere stretching. But as well, ECM is equally important in providing 
mechano-electrical conduction and serving as a homeostatic buffer, by its storage of latent growth 
factors (6,7,82). Increased accumulation of ECM causes stiffening of the heart muscle and 
impedes its normal physiological function of effectively pumping the blood to the body (3).
Cardiac fibrosis occurs in heart disease of various underlying causes such as local ischemia 
(induced e.g. by instability of atherosclerotic plaques), systemic disease (such as diabetes or 
chronic kidney disease) or as a result of chronic pressure overload (induced by aortic stenosis or 
arterial hypertension). While organs like skin, liver or intestine have a strong capacity to de-
differentiate and transdifferentiate their tissues as means of regeneration when needed, cardiac 
potential for regeneration is negligible (8). For example, myocardial ischemia results in permanent 
damage at the infarcted site, which compromises the tissue’s capacity for efficient contractile and 
electrical function. This is caused in part by the heart’s inability to replace ischemic tissue with new 
cardiomyocytes. Instead, damaged tissue is “healed” with a network of newly formed vessels and 
mesenchymal progenitors. Cardiomyocytes depend on aerobic oxidative metabolism, thus 
requiring steady energy supply. Therefore when necrotic injury occurs, muscle cells are replaced 




Extensive fibrotic remodelling is thus found in diseases with aggressive cardiomyocyte death. After 
acute ischemic damage, also known as myocardial infarction (MI), the obstruction of coronary 
arteries generally due to atherosclerotic instability leads to rapid cardiomyocyte death. Necrotic 
cells trigger an inflammatory reaction that activates reparative pathways that lead to debris removal 
and replacement with granulation tissue (an unorganised cellular structure formed by myeloid cells, 
fibroblasts, endothelial cells and ECM). Ultimately, a collagen-based scar is formed (Figure 1.1.). 
This fibrous replacement, termed replacement fibrosis, is adaptive at first although in the long term 
is detrimental, as the heart cannot work as efficiently as it did previously.
When CF does not involve macroscopic cardiomyocyte death, the fibrotic remodelling is gradual 
and insidious. Sublethal ischemic insults cause transient inflammation and disposal of ECM, 
predominantly scattered throughout the interstitium and around vessels, referred to as reactive 
interstitial fibrosis and perivascular fibrosis, respectively (Figure 1.1.). Pressure overload in the 
heart is generated in patients with conditions such as hypertension or aortic stenosis, and 
contributes to the development of extensive cardiac fibrosis, resulting in diastolic and systolic 
dysfunction. Volume overload due to valvular lesions also develops CF characterised with 
deposition of excessive non-collagenous ECM, formed by non-collagenous proteins such as 
laminins, tenascins, and fibronectin (3,9). Hypertrophic cardiomyopathy and post-viral dilated 
cardiomyopathy are also often associated with the development of significant cardiac fibrosis 
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Figure 1.1. Adverse cardiac remodelling. Histology image shows fibrotic features of fibrotic adverse 
remodelling: hypertrophic or atrophic cardiomyocytes, perivascular fibrosis surrounding a vessel, scattered 
interstitial fibrosis surrounding cardiomyocytes, and accumulation of fibre forming scars. Adapted from 
Weber et al 2012 (6). 
Introduction
(10,11). Furthermore, metabolic disturbances such as diabetes and obesity also manifest 
themselves in progressive fibrosis (12,13).
Regardless of the aetiology of fibrosis, cardiac fibroblasts are the central cellular effectors in the 
pathogenesis of CF. Cardiac fibroblasts are mesenchymal cells whose physiological function relies 
not only on the maintenance and ECM turnover and physical support of the muscle, but also on 
their contribution to homeostasis of the interstitial space and provision of an efficient 
communication between cardiomyocytes, as they may contribute to correct electromechanical 
coupling. They reside in the myocardial interstitium, epicardium and in the perivascular regions 
(14,15). While for years, fibroblasts were thought to be the largest non-myocyte contribution, this 
statement was revisited by Pinto et al in 2016, lowering this contribution to less than 20% of the 
total cardiac cell population. Instead endothelial cells are now believed to constitute the majority of 
non-cardiomyocyte cells in the heart and are likely to play a greater role in physiologic function and 
response to injury than previously anticipated (16).
Under stress stimuli, cardiac fibroblasts undergo a phenotypical and functional change and 
become activated myo-fibroblasts (15,17). Activated myofibroblasts are actively dividing, ECM-
producing cells that express alpha-smooth muscle protein (α-SMA), contractile stress fibres and an 
extensive endoplasmic reticulum. In the injured heart, alterations in mechanical stress, interstitial 
environment and expression of cytokines and growth factors dramatically impact fibroblast 
phenotype. It has been hypothesised that a subset of activated myofibroblasts fail to return to a 
quiescent state or to undergo apoptosis, therefore causing excessive cell accumulation and ECM 
production.
Resident fibroblasts in the heart represent a heterogeneous population due to the different sources 
they arise from at the embryonic development. Fibroblasts located in the interstitium are reported 
to arise from the developmental epicardium. Epicardial cells forming the epithelial outer layer of the 
heart, undergo epithelial-to-mesenchymal transition (EMT), a process tightly regulated by the 
expression of factors like fibroblast growth factors (FGFs) and transforming growth factor-beta 
(TGF-ß) signalling. During EMT process, platelet derived growth factor (PDGF) and TGF-ß 
contribute to the acquirement of the cardiac fibroblast phenotype. Furthermore, approximately 20% 
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of the adult cardiac fibroblasts distributed at the interventricular septum and left-ventricular free 
wall are reported to have an endothelial origin, as indicated by several studies through a process 
called endothelial-to-mesenchymal transition (EndMT). Furthermore, cardiac fibroblasts may arise 
from circulating cells and bone marrow derived progenitors (18-20). 
2. EndMT is a central hallmark of endothelial plasticity
Endothelial cells exhibit a vast degree of plasticity during development and adulthood. If we 
consider endothelial cells as a whole, the extent of their network becomes vast: the endothelium 
lines both blood and lymphatic vessels which provide nutrients and oxygen to virtually all parts of 
the mammalian organism (21). Therefore it is logical, and true, to think of the endothelium as 
highly heterogeneous as it is directly exposed to a broad spectrum of biochemical components 
carried by the bloodstream. Furthermore, it lines both capillary and central vessels as well as 
straight and branched segments, whose hemodynamics and shear stress generation vary 
greatly due to diameter, bloodstream speed and anatomical structures. Thus, throughout 
embryonic development endothelial cells are able to respond to diverse biochemical and 
haemodynamic stimuli and change their composition in response to the prerequisites of each 
location (22). Such extensive heterogeneity therefore requires significant plasticity. For example 
vessel regions that are exposed to different biomechanical forces exhibit different patterns of 
expression of genes pathophysiologically relevant in atherosclerosis (23). It is generally 
accepted, based on human swine and mouse models, that specific non-random focal sections of 
the endothelium are athero-prone or athero-susceptible. In fact they differentially express genes 
like V-CAM1, eNOS (the endothelial isoform of nitric oxide synthase), COX-2 (the inducible 
isoform of cyclooxygenase), and SOD (manganese-dependent superoxide dismutase). 
Furthermore, these areas also have different epigenetic marks, including site-specific 
differentially methylated regions of swine and mouse endothelial methylomes, histone marks 
regulating chromatin conformation, microRNAs and long noncoding RNAs (23,24).
Interestingly, failure of cardiomyocytes to successfully regenerate contrasts with remarkable 
cardiac endothelial plasticity. Cardiac endothelial regenerative capacity manifests after infarction in 
neonatal and adult hearts. This is thought to occur via a tyrosine-protein kinase kit (c-kit, also 
known as CD117) induction dependent process, as cell tracking studies show that endothelial cells 
generated post-infarction are c-kit positive. Thus, while c-kit is normally associated with 
cardiomyocyte precursors, a recent study has shown that although there is a strong induction of c-
kit at the infarcted area after injury, this induction is “overwhelmingly” associated with 
neovasculogenesis rather than myogenesis (25,26). That is, whereas c-kit positive cells give rise to 
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cardiomyocytes and endothelial cells in neonatal hearts, c-kit progenitors only give rise to 
endothelial cells in adulthood after injury. Somehow, adult cardiomyocytes seem to loose their 
plasticity during adulthood whereas endothelial cells maintain it. 
A central hallmark of endothelial plasticity that manifests during development and adulthood is 
EndMT (27-31). EndMT is a special type of cell fate conversion that involves the transformation of 
differentiated endothelial cells into mesenchymal cells. There is an evident disparity, almost direct 
opposition, between these two cell types (Figure 1.2); while endothelial cells form a monolayer, 
display apical-basal polarity, exhibit gap junctions and stay immobile; mesenchymal cells are 
loosely associated, have front-rear polarity, are less interconnected and exhibit migratory and 
invasive properties. During EndMT endothelial cells delaminate from the monolayer, lose cell-cell 
junction proteins such as CD31 (also known as PECAM1), VE-Cadherin, markers like TIE1 and 
Von Willebrand factor proteins, and gain mesenchymal markers such as fibroblast specific protein 
1 (FSP1, also known as S100A4), alpha-smooth muscle actin (α-SMA) and collagen proteins 
(COL1A1, COL3A1) (28,29). This transition may be reversible via a mechanism known as 
mesenchymal-endothelial transition, which is important in the context of cardiac neovascularization 
(30).
Canonical transcription factors that drive EndMT are zinc-finger containing proteins Snail and Slug, 
encoded by Snai1 and Snai2 genes (32-34). Snail is activated upon inducers such as TGF-ß, 
Notch and hypoxia signalling, and binds to conserved E-box elements at the promoter regions of 
VE-cadherin, directly transcriptionally repressing endothelial cell adhesion transcription (36). Snail 
alone is able to induce epithelial to-mesenchymal transition (EMT) (37), therefore is thought to 
have several molecular targets. Snail induces vimentin, known to be involved in stimulation of 
stress fibre expression and inducing changes in the cytoskeleton to facilitate mobility and cell 
migration (37). Furthermore, Snail is upstream of mesenchymal molecules such as matrix 
metalloproteinase 2 (MMP-2) (38) and fibronectin (39). One interesting feature in Snail biological 
function is its potential to protect cells from death and provide resistance to DNA damage, 
according to studies in epithelial cells (40,41). This is consistent with the fact that endothelial cells 
show apoptotic resistance as they undergo EndMT when they encounter apoptotic signals such as 
TGF-ß and hypoxia. Slug is also up-regulated in developmental EndMT and known to be a direct 
target of TGF-ß 2. Twist is another recurrent inducer of EndMT. The expression of Twist, a basic 
helix-loop-helix transcription factor, is as well linked to cancer-EMT and endocardial EndMT (42). It 
is reported to be regulated by BMP2 (42), a member of the TGFβ family that has been implicated 
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in cardiac cushion EndMT. Twist is also induced by hypoxia in cancer and by TGF-ß-induced 
EndMT (43, 44, 103). Thus Snail and similar EMT-inducing transcription factors coordinate 
reprogramming of endothelial cells towards a mesenchymal phenotype. 
3. Developmental EndMT
EndMT has been first and best described in embryonic development during heart formation 
(45,18,46). During cardiac valve and septa formation a subset of endothelial cells of the primitive 
endocardium expressing Tie-1, Tie-2, VEGFRI/II and CD31 undergo EndMT to give rise to 
primordial septa and valves in a spatiotemporally restricted manner. In murine heart this process 
has been accurately described (18). At embryonic day 8.5 the mouse heart is a tube composed by 
three layers: i) the inner endocardium, ii) the cardiac jelly, formed by ECM secreted primarily by the 
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Figure 1.2. Endothelial-to-mesenchymal transition (EndMT). Endothelial cells form a monolayer, exhibit 
apical-basal polarity (A-B polarity) and express cell-cell adhesion proteins such as vascular endothelial 
cadherin (VE-cadherin), platelet endothelial cell adhesion molecule 1 (PECAM 1) and typical proteins Tie1, 
Tie2 and Von Willebrand factor (vWF). EndMT is induced by diverse external and internal stimuli, including 
transforming growth factor beta (TGF-ß) proteins, Notch signalling ligands, canonical Wnt pathway ligands, 
ras hyperactivity, reactive oxygen species (ROS) generated by hypoxic conditions, shear stress, high 
glucose levels, and others. EndMT is modulated by the transient expression of EndMT transcriptional 
factors such as Snail, Slug, Twist, and ZEB1, which are involved in repressing endothelial proteins and 
activating the expression of mesenchymal-related genes. Mesenchymal-like cells derived from EndMT 
acquire migratory and invasive capacities, exhibit front-rear polarity (F-R polarity), are loosely associated 
and express mesenchymal typical proteins such as alpha-smooth muscle actin (αSMA), Collagens I and III 
(COL1A1 and COL3A1), Vimentin, Fibronectin, fibroblast specific protein 1 (FSP1) and extracellular matrix 
(ECM) regulatory proteins such as matrix metalloproteinases (MMPs). The process may be inhibited via 
bone morphogenic protein 7 (BMP 7) and vascular endothelial growth factor A (VEGF-A) (27-43). 
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outer layer, iii) the primitive myocardium. At day 9.5, signals from the myocardium activate a subset 
of endocardial cells from regions of the outflow tract and atrioventricular (AV) canal undergoing 
EndMT. These selected EndMT-cells acquire a migratory phenotype and invade the cardiac jelly, 
forming the endocardial cushions. This then contributes to cardiac valve formation and heart 
septation.
Functional studies in mouse and chicken prove that TGF-ß signalling factors TGF-β 2 and TGF-β 3 
are essential for endocardial cushion formation (47). Moreover, Ras signalling plays as well a 
critical role in cushion formation as indicated by studies in NF1 deficient embryos, a model where 
Ras activity is activated as a consequence of the loss of Ras activator NF1 (48).
Developmental EndMT also contributes to the thickening of vessels as shown in studies in chick 
swine and cow in which endothelial cells undergo EndMT and acquire a smooth muscle cell 
(SMCs)-like phenotype accumulating at the intima (the outer layer of the vessel in direct contact 
with the endothelium) (49,50). Similar processes of intimal thickening have been found in 
pulmonary development (51). As such, the contribution of EndMT as a source of mural cells during 
development makes it particularly important in angiogenesis and arteriogenesis processes as 
EndMT may provide the necessary support to trigger the advancement of vessel formation. 
Moreover it has been reported that EndMT-derived pericytes and SMCs exhibit proliferative 
capacity (49), and therefore angiogenic potential. Interestingly tip cells, during angiogenic sprouting 
are endothelial cells lacking in lumen with the capacity for migration (54), a phenotype consistent 
with an EndMT phenotype. It has been speculated that endothelial tip cells may acquire an EndMT 
phenotype and thereafter remain with a mesenchymal phenotype indefinitely (52,53).
4. EndMT in disease
It is commonly accepted that re-activation of developmental processes in adulthood often has 
pathological consequences (55). EndMT is no exception to this phenomenon. Indeed, EndMT is a 
recurrent mechanism after tissue injury, although its pathological contributions differs between 
studies. The first reports of EndMT in adulthood only appeared in the last decade and the majority 
of such studies categorise EndMT as a deleterious mechanism, thus portraying the link between 
EndMT and pathologies involving different organs. 
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4.1. EndMT in cardiac fibrosis
Cardiac fibrosis was the first pathology where EndMT was described in the adult organism in a 
study by EM Zeisberg and colleagues a decade ago (56). Using lineage tracing studies they 
showed for the first time that a significant percentage of fibrotic cells in a mouse model of cardiac 
fibrosis had an endothelial origin. In the in vivo study, using a Cre-loxP recombinase system under 
Tie-1 promoter, cells with endothelial origin expressed LacZ regardless of subsequent phenotypic 
conversions. Furthermore FSP1-GFP reporter mice could show cells double expressing CD-31 and 
FSP-1, indicating cells in an intermediate EndMT state (expressing of both mesenchymal protein 
FSP1 and endothelial CD31 protein). Importantly, evidence of EndMT was reported only in fibrotic 
mice and not in sham control models. Similarly, experiments using murine models of MI in which 
mice undergo ligation of the left ascending coronary artery (LAD) and subsequent ischemia, 
together with cell lineage tracing studies have reported evidence of EndMT in scars produced after 
experimental MI. They linked EndMT-derived α-SMA positive cells to canonical Wnt signalling 
activation (57). 
Recently the role of EndMT in diabetes mellitus-induced cardiac fibrosis was also investigated. 
High levels of plasma endothelin-1 (ET-1) in diabetic patients were linked to cardiac fibrosis and 
EndMT (58). Widyantoro and colleagues found that in diabetes mellitus cardiac ET-1 expression is 
up-regulated in vivo and the diabetic phenotype is ameliorated in a vascular endothelial cell-
specific ET-1 knockout mice, highlighting the importance of an endothelial-related regulatory 
process. In the study, fibrotic areas exhibited endothelial cells co-expressing CD31 and FSP1 
markers, indicating EndMT. Moreover, high glucose alone has been identified as an inducer of 
EndMT in human cardiac endothelial cells, an effect that has been replicated in vivo and 
ameliorated by using a glucagon analog drug, thus reducing EndMT and cardiac fibrosis (59, 60).  
Endocardial fibroelastosis (EFE) is a severe cardiac fibrotic condition in which the ventricular 
endocardium undergoes a fibro-elastic thickening causing left ventricular hypoplasia and 
obstruction of left ventricular outflow. In a study by Xu et al, human patient samples from EFE 
tissue were analysed and it was found that every patient sample contained endothelial cells co-
expressing alpha-SMA and FSP-1 mesenchymal markers, indicative of EndMT (44). Further 
analysis of patient tissue vs control showed that EFE samples exhibited bone morphogenic 
protein-7 (BMP-7) signalling differentially and epigenetically suppressed. BMP signalling is 
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antagonistic to TGF-ß signalling which is a known inducer of EndMT and will be subsequently 
addressed in this thesis. 
4.2. EndMT in fibrotic pathologies
EndMT has been meanwhile also directly implicated in the pathophysiology of fibrogenesis of 
numerous other organs such as the kidney, the lung and the gut (61-70).
In pulmonary fibrosis the occurrence of EndMT is well established; EndMT orchestrates bleomycin- 
and radiation-induced pulmonary fibrosis (63,64). Recently several studies have also demonstrated 
the involvement of EndMT in pulmonary hypertension (PH). In a model of PH, endothelial lineage 
studies revealed endothelial cells at neointima expressing smooth muscle phenotype-like markers. 
This has also been detected in human pulmonary arterial hypertensive (PAH) neointimal lesions 
(65), and in patients of sclerosis-associated pulmonary artery hypertension (66). In a parallel study 
Ranchoux et al identified EndMT in PAH patients and then using transmission electron microscopy, 
correlative light and electron microscopy the study provided unequivocal ultrastructural-level 
evidence of ongoing dynamic EndMT in pulmonary hypertension samples (67). Furthermore 
EndMT also plays a role in non small cell lung cancer (68).
The substantial contribution of EndMT to the pathophysiology of renal fibrosis has also been 
largely demonstrated. Together with its closely related mechanism epithelial-to-mesenchymal 
transition (EMT), EndMT contributes significantly to the accumulation of fibroblasts. This has been 
shown by EM Zeisberg and colleagues in murine fibrotic models of different sources, including 
unilateral ureteral obstruction (UOO), a model that depicts progressive tubulointerstitial fibrosis, 
streptozotocin-induced diabetic nephropathy, and α3 chain of collagen type 4 knockout mice (a 
model for Alport syndrome, with an acute fibrotic phenotype). Their findings show co-localisation of 
CD31 and α-SMA of stromal cells in all models (62). These studies have been further corroborated 
in early development of interstitial kidney fibrosis in STZ-induced diabetic nephropathy by Li and 
colleagues, in which lineage tracing analysis using Tie2-cre recombinase was used to find a 
significant number of fibroblasts of endothelial origin (69).
EndMT has been also detected in models of fibrotic bowel pathologies such as inflammatory bowel 
disease and colonic fibrosis (70) using Tie2–green fluorescent protein (GFP) reporter–expressing 
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mice. Furthermore, induction of EndMT has an important role as a source of cancer associated 
fibroblasts (CAFs) in solid tumor progression and pancreatic cancer (53).
4.3. EndMT in atherosclerosis
EndMT has only recently been linked with atherosclerosis (71,72). Atherosclerosis is a vascular 
immuno-inflammatory disease that appears in focal localised regions of large and medium-sized 
arteries in which disturbed laminar flow, such as at branch sites and bifurcations, is present. 
Proximal parts to the heart at the aortic root are also greatly affected. Atherosclerosis is the leading 
cause of death in Western countries, a statement which is shortly anticipated to be globally 
applicable (73). The pathophysiology of atherogenesis involves decades-long expansion of the 
arterial intima due to the accumulation of lipids, cells, and ECM. Whereas atherosclerosis alone is 
not per se fatal and generally the process does not lead to major symptoms when the lumen of the 
artery is preserved, in a few cases focal lesions of the intima lead to necrotic development 
(atherosclerotic plaques). These complications may lead to acute, occlusive thrombosis in 
coronary arteries, leading to the fatal consequences of myocardial infarction, unstable angina and 
sudden cardiac death or to stroke when cerebral arteries are affected (74). Endothelial cells at 
athero-prone sites suffer severe damage and develop a dysfunctional phenotype characterised by 
altered nitric oxide metabolism and vascular reactivity, increased lipoprotein permeability and 
oxidation, increased monocyte adhesion, altered ECM metabolism and dysregulation of 
hemostatic-thrombotic balance (23). Often, these areas even become de-endothelialized 
(denuded) on advanced lesions, raising the question of whether these endothelial cells have died 
or transitioned to a mesenchymal fate. 
In vitro and in vivo studies in porcine and human tissues have shown that laminar flow inhibits 
EndMT whilst disturbed flow activates EndMT in valvular aortic endothelial cells, contributing to 
fibroproliferative vascular damage. More importantly, EndMT has been identified in  atherosclerotic 
lesions (71,72). Using Tie1- and Tie2- cre recombinase mice to trace mesenchymal cells of 
endothelial origin, positive cells have been identified directly at the intima and adventitia of 
atherosclerotic plaques. It has been speculated that EndMT is induced by TGFß-1 expression and 
high oxidative stress conditions. Moreover, EndMT has been associated with unstable human 
plaques, by co-localisation of CD31 and mesenchymal markers Fap (Fibroblast activation protein) 
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and FSP1.It has been hypothesised that the reason EndMT leads to plaque instability is because 
EndMT derived-fibroblasts have deleterious MMP activity; that is they aberrantly produce more 
extracellular MMPs and TIMPs, which decreases the quality of the fibrous cap and damage ECM 
homeostasis (72).
5. EndMT inducing signals
EndMT program can be activated by several diverse but connected external and intrinsic signals. 
EndMT’s regulation is controlled by tight regulatory mechanisms. A tight regulation is critical to 
maintain the integrity of the endothelium and avoid aberrant fibrotic processes. As such, signalling 
pathways involved in regulating EndMT are, not surprisingly, well established pathways already 
known for their essential role in controlling other critical cellular fate decisions such as division, 
migration, senescence or apoptosis. Subsequently, we are providing an overview of the best-
studied signalling pathways and microenvironmental factors known to induce EndMT. We are 
aware, however, that it is far from complete, as the regulation of EndMT is an active field of 
research and mechanistic insight into EndMT is growing rapidly. 
5.1. TGF-β signalling
TGF-ß is a multifunctional growth factor that belongs to the large TGF-ß superfamily of pleiotropic 
growth factors. TGF-ßs are involved in critical cellular processes such as growth, cell division, 
apoptosis, senescence and migration (75-77). The members of the TGF-β superfamily include two 
major branches, bone morphogenetic proteins (BMPs) and TGF-β/activin A subfamilies. All TGF-β 
family members are homodimeric proteins that interact with transmembrane TGF-β receptors.
In the adult organism TGF-ß is released to extracellular space by a variety of cell types, including 
fibroblasts, macrophages and cells from the parenchyma, contributing to tissue homeostasis and 
tissue repair. TGF-ß can be found in 3 isoforms, TGF-beta 1, TGF-beta 2 and TGF-beta 3, which 
share high similarity and homology but are coded by three separated genes (78). The three 
isoforms are multifunctional and can act in autocrine, paracrine and endocrine manner (80) and are 
believed to have overlapping and distinct effects, depending on the cell context. For example, while 
having growth inhibitory effects in a subset of epithelial cells and myeloid cells, they cause 
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proliferation of fibroblasts (76,79). TGF-ß is synthesised as a precursor protein that is 
proteolytically processed. TGF-ß is released to the extracellular space as an inactive latent 
complex, the LLC (large latent complex), that after a series of proteolytic steps regulated by 
proteins from the ECM, and processed by BMP1 and some MMPs in a tightly regulated process, is 
converted into the mature TGF-ß form. Mature TGF-ß acts as an extracellular ligand that binds to a 
complex of receptors at the cell membrane (81,82).
The TGF-β signals are transmitted through specific transmembrane type I and type II serine/
threonine kinase receptors (83,84). In endothelial cells, TGF-β binds two distinct type I receptors, 
ALK1 and ALK5, to activate ALK1/Smad1/5/8 and ALK5/Smad2/3 signaling pathways. ALK1 
induces Smad1/5 phosphorylation, leading to increased endothelial cell proliferation and migration 
and cytoskeleton reorganisation, while ALK5 promotes Smad2/3 activation and promotes 
quiescence and permeability (86). These two pathways regulate different genes and exhibit 
antagonistic biological functions in endothelial cells. Interestingly, endothelial ALK5 activity is 
necessary for ALK1 signalling (87). Nevertheless, it seems that the effect of ALK1 is also 
dependent on cellular context (85).
TGF-ß regulates endothelial cell plasticity and is one of the greatest inducers of developmental 
EndMT (89). Studies from knockout mice have shown that signals activating EndMT in the heart 
development include multiple TGF-ß isoforms and downstream signalling proteins and receptors. 
TGF-ß co-receptor Endoglin, is required for successful formation of the endocardial cushions. In 
vitro and in vivo studies have shown that TGF-β efficiently induces EndMT in different types of 
endothelial cells, including human, swine and mouse. The molecular mechanism behind TGF-β 
induced EndMT involves Snail signalling activation. In mouse embryonic stem cell-derived 
endothelial cells TGF-β 2 induces EndMT and expression of Snail. Importantly, activation of Snail 
is essential for TGF-β  to induce EndMT. Finally, TGF-β -induced EndMT has been achieved via 
Smad-dependent and independent ways (90-92).
5.2. Notch signalling pathway
Various studies have identified a critical role for Notch signalling in EndMT (93,112). The 
evolutionarily conserved Notch regulates cell fate specification through local cell interactions in 
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both vertebrates and invertebrates. Notch signalling is known to regulate multiple cellular 
processes and is essential to endothelial development. In adulthood, Notch regulates stem cell 
maintenance and tissue homeostasis (94). Notch multiple homolog genes are expressed at many 
sites in the developing organism and code for transmembrane receptors whose typical structure 
contains an extracellular segment comprised of a variable number of epidermal growth factors 
(EGF)-like repeats, a transmembrane fragment and an internal cytosolic region termed the NICD 
(notch-intracellular domain) that contains nuclear localisation signals. Notch receptors interact 
specifically with canonical membrane-bound DSL ligands Delta, Serrate and Lag2, found in 
Drosophila. The mammalian DSL ligands counterparts account for Delta-like (Dll1, Dll3 and Dll4) 
and Serrate-like (Jagged1 and Jagged2) ligands. Notch ligands are type 1 cell-surface proteins 
that, similarly to Notch, contain EGF repeats at the extracellular domain together with the so-called 
DSL domain, which is thought to be required for Notch binding. Jagged ligands have a longer 
structure than Delta-like ligands, and contain almost double the number of EGF-repeats and other 
sequences of so far unknown function. The intracellular region of DSL ligands have 2 distinct 
domains that serve for ligand intracellular signalling and interactions with the cytoskeleton (95). 
To activate Notch signalling, an interaction of DSL ligand of one cell (the signal-sending cell) and 
the extracellular part of Notch receptor of an adjacent cell (signal receiving-cell) is needed. Ligand 
binding triggers additional proteolytic cleavages of Notch, first by a disintegrin and metalloprotease 
(ADAM) within the juxtamembrane region followed by γ-secretase within the transmembrane 
domain resulting in the release of the Notch intracellular domain (NICD) from the membrane. NICD 
translocates to the nucleus where it directly interacts with the CSL (CBF1, Su(H), LAG1) 
transcription factor and recruits co-activators including Mastermind to turn on expression of Notch 
target genes such as hairy and enhancer of split related proteins (Hes and Hey) (95-99). 
Notch is directly involved in inducing endothelial EndMT in the context of murine fibrosis (112). 
NICD overexpression in zebrafish embryos leads to hyper cellular cardiac valves, whereas 
inhibition of Notch signalling leads to detrimental valve development (100). Notch induces EndMT 
by directly targeting transcriptional factors Snail and Slug (101,102). Accordingly, activation of 
Notch in the context of TGF-β stimulation results in synergistic up-regulation of Snail in endothelial 
cells. Furthermore, Jagged1 ligand can also induce EndMT (103). Unpublished experiments made 
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in our lab showed that EndMT was induced in human cardiac endothelial cells by application of 
exogenous Jagged1 recombinant protein ligand (data not shown).
5.3. Canonical Wnt signalling
Canonical Wnt signalling is an autocrine and paracrine transduction signalling pathway that, 
similarly to Notch, activates gene transcription by extracellular receptor activation. Briefly, Wnt 
canonical pathway activates downstream gene expression by nuclear accumulation of protein ß-
catenin, which otherwise localises at the inner site of plasma membrane and is rapidly degraded by 
a degradation complex formed by AXIN2 and others. Soluble Wnt ligands bind to Frizzled 
receptors, activating the pathway by halting ß-catenin degradation and consequent accumulation 
at the nucleus, which leads to activation of targeted genes (104,105). In the context of diabetic 
kidney disease, blockage of canonical Wnt signalling reduces EndMT and fibrosis (106). Moreover, 
in MI murine samples, mesenchymal cells of endothelial origin show activation of Wnt by 
accumulation of nuclear ß-catenin (57). Furthermore, in vitro pharmacological accumulation of ß-
catenin induced mesenchymal phenotype in bovine aortic endothelial cells (57,107).
5.4. Ras
Ras GTPase activity is known to regulate a myriad of biological processes, widely acknowledged 
for its critical role in malignant transformation and cancer. Ras activation’s ultimate cellular effects 
depend essentially of the cell context (109). In kidney fibroblasts, TGF-ß induces fibroblast to 
myoblast transformation in a Ras-related mechanism (101). In pulmonary fibrosis, Hashimoto and 
colleagues demonstrated that Ras and TGF-beta cooperation is necessary in order to induce in 
vitro-EndMT (63). Furthermore, loss of Ras activity inhibitor RASAL1 is known to be significantly 
down-regulated by epigenetic silencing in EndMT cells in a model of murine cardiac fibrosis and in 
in vitro experimental EndMT in human endothelial cells (111). 
5.5. Hypoxia
EndMT is induced under hypoxic conditions in vivo and in vitro (113,115,116). Developmental 
angiogenesis is known to be triggered by hypoxia, as hypoxia inducible factor 1-alpha (HIF-1alpha) 
induces VEGF which promotes endothelial tip formation and sprouting angiogenesis. In vitro, 
EndMT is induced when exposing human cardiac endothelial cells (HCAEC) to hypoxia conditions 
 14
Introduction
(1% oxygen) during 4 days, as cells show a decrease in CD31 expression, VE-cadherin and 
increase of a-SMA, COL1A1, and EndMT transcription factors Snail, Slug and Twist. HIF1-alpha is 
a direct target of Snail, by binding to Snail promoter region and inducing Snail expression (22,36). 
5.6. Inflammation
Inflammatory mechanisms are activated in every context of cardiac fibrosis (114). After MI, cell 
death triggers an acute inflammatory reaction to initiate the reparatory fibrotic process, inducing 
infiltration of leukocytes and myeloid cells to the infarcted myocardium, followed by activation of 
inhibitory mediators such as TGF-ß, whose function in that context is to promote inflammatory cell 
death whilst promoting fibrosis (4,79). Inflammatory cytokines TNF-α, IL1-ß, and IL-6 are first 
released post-MI. Models of progressive cardiac fibrosis caused by hypertension or aortic stenosis 
exhibit significant induction of inflammatory cytokines TNF-α and IL1-ß, inflammatory CXC 
chemokines MIP-2 and IP-10, and CC chemokine MCP-1 in pressure overload murine models 
(113,79) . 
In vitro studies with exogenous application of inflammatory cytokines IL-6 and TNF-α have shown 
successful induction of EndMT in porcine aortic valve endothelial cells and cytokines IL-1ß and 
TNF-α in embryonic and adult human valvular endothelial cells (117,120). Another study found that 
TGF-ß 2 and IL1-ß had an additive effect in EndMT induction in HUVECs, in a manner dependent 
of NFκB signalling (118). Additionally, complement cascade antagonists have been shown to 
reduce EndMT (119). However, detailed mechanisms of how inflammatory signals regulate EndMT 
in vivo are still only incompletely understood.
6. Macrophages
Macrophages are known for their integral role in innate immunity as first line defenders against 
pathogens and tissue damage. However, macrophage functionality goes far beyond defence, and 
macrophages are nowadays increasingly considered as essential regulators of vertebrate biology, 
therefore representing a powerful target for an expansive list of pathologies (121-124).
For decades, it was believed that adult tissue-resident macrophages were continuously 
replenished by blood-circulating monocytes, in a concept described by Van Furth and colleagues in 
the 1970s known as the “mononuclear phagocyte system” (MPS). The foundational concept stated 
that macrophages terminally differentiate within their fate tissue without capacity to proliferate, 
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therefore requiring continuous replacement from blood derived monocytes (125). However, the 
knowledge of macrophage ontogeny has dramatically changed and concepts are currently being 
rewritten. Nowadays it is known that the MPS paradigm is true for only a number of murine tissues 
under homeostasis, such as gut, dermis, pancreas and peritoneum, whereas resident 
macrophages in other tissues like the brain and heart have an embryonic origin and are able to 
proliferate (126-129). 
During development, macrophages are derived from two sources. In mice, yolk sac (YS) derived-
macrophages appear from day 8 (E8.5), and a second wave of macrophages is produced via 
definite hematopoiesis in the liver, in a process where hematopoietic stem cells (HSCs) appear 
within the hematogenic endothelium at E10.5 and migrate to the fetal liver where they expand and 
differentiate starting from E12.5., where the liver becomes the main hematopoietic organ and 
generates all hematopoietic lineages, including monocytes (130,131).
Nevertheless, the MPS system still applies to inflammatory conditions. Massive recruitment of 
monocytes to tissues occurs upon tissue injury or infection, a process that takes place 
simultaneously with the proliferation of resident macrophages. Once inflammation has been 
contained, resident macrophages may rebuild the total macrophage pool by local proliferation or 
newly recruited cells may take up residence by acquiring self-renewal capabilities and tissue-
resident effector functions. These processes may depend on the nature of the insult and the tissue 
and organ where inflammation takes place (132,133).
7. Macrophages in inflammation
Macrophages are myeloid cells of the innate immune system that are primarily considered as 
“homeostasis keepers” due to their ability to sense any perturbation and to respond with a broad 
range of activities (from tissue-dependent tasks to general immune effector functions) (123,124). In 
fact, inflammation caused by either pathogens or injury may be considered as an extreme 
disruption of homeostasis, that calls macrophages into action to restore tissue integrity and 
functionality. 
Macrophages continuously survey their surroundings to detect anomalies, such as foreign invaders 
or tissue damage, and respond accordingly by initiating inflammation and by eliminating the threat 
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by phagocytosis and production of enzymes, anti-microbial peptides and reactive oxygen species. 
In addition, as major cytokine and chemokine producers, macrophages orchestrate inflammation 
and regulate the recruitment of other leukocyte populations. Moreover, macrophages participate in 
the adaptive immune response by presenting antigen via major histocompatibility complexes 
(MHCI and MHCII) to T and B lymphocytes, and by clearing pathogenic agents in the humoral 
response of B lymphocytes. Furthermore, macrophages are essential regulators of resolution of 
inflammation and are involved in wound healing processes by secreting anti-inflammatory 
mediators, remodelling of extracellular matrix and promoting angiogenesis. In line with their critical 
role in tissue homeostasis, deregulation of the macrophage effector functions results in numerous 
pathologies (133-140). 
8. Macrophage activation
Another aspect of macrophage functional specialisation manifests when a macrophage encounters 
endogenous or exogenous pathogenic insults. Over the last several years in macrophage 
literature, the terms polarisation and activation have been, often mistakenly, widely 
interchangeable. A macrophage is activated when a stimulus, a perturbation of the steady state, 
such as a cytokine or toll-like receptor (TLR) agonist produces a response, which generates 
distinct patterns of gene and protein expression in the macrophage. Thus, the specific features of 
the macrophage reaction towards the stimulus is critically dependent on the surrounding 
environment at the moment of the insult and on previous instructions received during the 
macrophage’s lifetime. Therefore, macrophage activation relies on the integration of signals 
derived from their ontogeny, differentiating factors, cytokines, metabolites and ligands for 
pathogen-/danger-associated molecular patterns (PAMPs/DAMPs). As a consequence, 
macrophages can acquire an almost infinite number of polarisation states, which has led to the 
hypothesis of the “spectrum model” of macrophage activation (135) (Table 1.1). In this context, 
macrophages are classified according to the factors which they have been primed with 
(polarisation) and to the type of response they carry out upon a pathogenic challenge (activation)
(141). For example, macrophages primed with cytokine IL-4 may be classified as M-(IL-4), and so 
on. For the sake of simplicity, this classification has been classically divided in two main groups 
according to the macrophage’s response to the pathogenic insult. Thus, macrophages can either 
be pro-inflammatory (also found in literature as “M1” or “M1-like” macrophages) or anti-
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inflammatory (“M2” or “M2-like”). M1-like, pro-inflammatory macrophages secrete TNF-α, IL-12, 
IL-6 and IL-23 upon activation with PAMPs and DAMPs and exhibit high antigen-presenting 
capabilities, whereas anti-inflammatory, “M2-like” macrophages produce IL-10 and are highly 
phagocytic and pro-fibrotic. Macrophages can be further classified according to the differentiating 
and/or activating cytokines and factors. Therefore macrophages exposed to IFNγ or GM-CSF 
become pro-inflammatory, whereas macrophages treated with IL-10, IL-4, IL-13, glucocorticoids or 
M-CSF preferentially display anti-inflammatory functions. Needless to say, these in vitro derived 
macrophage populations are a simplification that reflect only discrete aspects of in vivo 
macrophages (142). Nevertheless, in vitro-polarised macrophages have proven very useful in the 
study of macrophage biology since many of their specific responses and behaviours have been 
confirmed in vivo (143).
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Table 1.1. Marker systems for activated macrophages. This schematic shows functional subdivisions 
according to stimulation of mouse CSF-1 macrophages with the existing M1-M2 spectrum concept 
(Martinez and Gordon, 2014; Mosser and Edwards, 2008; Stout and Suttles, 2004). Stimulation conditions 
are IL-4, LPS, LPS and IFN-g, and IFN-g alone. Marker data were drawn from a wide range of published 
and unpublished data from the authors’ laboratories and represent a starting consensus (Edwards et al., 
2006; Fleetwood et al., 2009; Gratchev et al., 2008; Gundra et al., 2014; Krausgruber et al., 2011; Lang et 




Macrophages are present in the healthy heart and are the main population after myocytes, 
fibroblasts and endothelial cells. The concept that cardiac macrophages are continuously 
replenished by haematopoietic stem cells has remained elusive for long, and was recently 
examined by several studies that characterised cardiac macrophage ontogeny in homeostasis and 
stress (144-146). Now evidence suggests that macrophages are present in the murine myocardium 
as early as day E9.5 of embryonic development, which indicates that they originate from the 
embryonic yolk sac (YS) as fetal liver haematopoiesis occurs from day E11.5. However, a second 
wave of macrophages derived from fetal liver does invade the myocardium later. Interestingly, YS 
macrophages in the heart are maintained through adulthood and are not substantially replaced by 
fetal liver or bone marrow-derived monocytes, unlike in other tissues such as skin macrophages. 
Embryonic cardiac macrophages form different subsets and exhibit differential functions. YS-
macrophages are CCR2-negative and exhibit angiogenic potential, in contrast with the 
macrophage subset derived from fetal monocyte haematopoiesis, which is CCR2-positive and 
exhibit a pro-inflammatory gene expression profile. Adult cardiac macrophages are self-renewing 
during homeostasis and benefit from circulating monocytes as a source of cell maintenance. Still, 
when resident macrophages are experimentally depleted, bone marrow stem cells are able to 
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Figure 1.3. Resident macrophage heterogeneity in the heart. The most abundant populations originate 
from YS progenitors, are able to self-renew, and are CCR2— Ly6C—. This population can be further 
dissected into MHCIIhi (shown in green) and MHCIIlo (shown in yellow). The second, smaller pool of 
resident cardiac macrophages is developmentally dependent on embryonic haematopoietic stem cells 
precursors, which are maintained from circulating monocytes under steady state conditions. These cells 
can be further subdivided into CCR2— (shown in violet) and CCR2+ (shown in brown) populations. 
Although, LyC— resident macrophages do not depend on circulating monocytes for maintenance under 
homeostatic conditions (left), during cardiac stress (right), recruited Ly6C+ blood monocytes can 
differentiate into all resident cardiac macrophage subsets, which can subsequently expand and proliferate, 
thus restoring homeostasis within the heart by local proliferation and HSC-derived recruitment. (Adapted 
from B. Cohen and M. Mosser, Cell 2015).
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repopulate the myocardium, and re-establish all subsets identified in normal healthy hearts. During 
angiotensin II injection, macrophage numbers are increased substantially via both monocyte 
recruitment and proliferation of resident macrophages (Figure 1.4.) (144,146). 
This is corroborated by Epelman et al, who identified adult-derived macrophages derived from 
monocytes but also from local proliferation and reported the additional nuance that monocyte 
derived macrophages are involved in coordinating cardiac inflammation, while having a less 
important role in functions like antigen sampling and efferocytosis (126). Furthermore, it has been 
revealed that embryonic origin-derived macrophages in the adult heart have a protective, wound 
reparative role, whereas monocyte recruited macrophages lack such repair properties (145).
10. Objectives
EndMT is a process that contributes to the mesenchymal phenotype in fibrotic diseases, and even 
though biochemical inducers of EndMT have been delineated, cellular sources and effectors that 
impact EndMT are not well established. Macrophages have a critical role in modulation of cardiac 
inflammation, healing and fibrosis and as knowledge on the vast variety of functions that 
macrophages have upon other cell types and their microenvironment is  increasing, the impact of 
macrophages on endothelial cells in context of EndMT has not yet been addressed. Based on this, 
we aimed to explore if a potential crosstalk between macrophages and endothelial could impact 
EndMT and/or macrophage polarisation. More specifically we aimed to test if cardiac macrophages 
are involved in inducing EndMT in the context of cardiac fibrosis and atherosclerosis and also if 
endothelial cells undergoing EndMT impact macrophage polarisation. The aims of the present 
thesis were therefore the following:
i) to evaluate macrophage and EndMT load in human tissue and in mouse models of 
cardiac fibrosis and cardiovascular atherosclerotic disease 
ii) to explore whether macrophages induce EndMT in vitro.
ii a) to elucidate which macrophage phenotype is responsible for EndMT induction
ii b) to investigate the putative cellular and molecular mechanisms involved in 
macrophage-induced EndMT









The cell lines used in this study are listed in table 2.1.
Table 2.1: cell lines
2.1.1.2. Primary cells
Peritoneal macrophages and bone marrow-derived macrophages were harvested from 10 weeks 
old C57BL/6N mice purchased from Charles River Company. 
2.1.1.3. Patient samples
Human heart tissues from cardiac infarction, aortic stenosis and diabetic cardiomyopathy patients 
were obtained from autopsy samples obtained from the Department of Pathology at UMG 
(Göttingen Medical Center).
cell line cell type characteristics Obtained from reference
C2C12 murine skeletal 
muscle cells
Prof Lehnart UMG 
Göttingen
(151)
HeLa human epithelial adenocarcinoma UMG Göttingen (149)

















Prof M Zeisberg 
UMG Göttingen
(150)
RAW 254.7 murine acrophages Abelson murine 
leukemia virus 
transformed,biosafet
y level S2 
Prof Uwe Raaz UMG 
Göttingen





2.1.2. Cell culture media and additives
All media and additives used for the culture of cells lines and primary cell s are listed in Table 2.2.
Table 2.2: cell culture materials
2.1.3. Chemicals and reagents
All chemical reagents used are presented in Table 2.3.
name provider order number
DMEM Sigma-Aldrich D5796
Fetal calf serum Sigma-Aldrich F4135-500ML
HEPES 1M Sigma-Aldrich 15630080
Penicillin/Strepromycin Solution Gibco 15140-122
Phosphate buffered saline Gibco 14190-094
Piruvate Sigma-Aldrich 28374849
Beta-Mercaptoethanol for cell culture 
50 mM
Gibco 31350-010
L-Glutamine (200 mM) Gibco 25030081
ACK Lysing Buffer ThermoScientific A1049201
Accutase® Solution Sigma-Aldrich A6964-100ML
FM2 medium ScienCell 2331b
FM2 basal medium ScienCell 2331
CellTracker™ orange CMTMR Dye ThermoScientific C2927
Trysin-EDTA 0,25% Sigma-Aldrich T4049-100ML
 Glutamax TM Sigma-Aldrich 3345-100ML
name provider ordering number
Ethanol ROTH 5054.1
Fast SYBR green Applied Biosystems 4385612
Glycin MERCK 1.04201.0100 






Magnesium Chloride Solution 25mM Sigma-Aldrich M8787-1.5ML
Nuclease-Free Water QIAGEN 129114
OligodT 12-18 Primers Invitrogen 58862
Non fat powdered milk ROTH T145.2
Trizol Ambion 15596-026
Tween20 Sigma-Aldrich P1379-500ML
Weigert’s iron hematoxylin solution Sigma-Aldrich HT1079
Xylol ROTH 9713.3
Lipopolysaccharides from 
Escherichia Coli O55:B5 (LPS)
Sigma-Aldrich L6529-1MG
Ponceau reagent ROTH 3469.1
SDS loading buffer Novex 96868
NP-40 Lysis buffer Invitrogen FNN0021
NuPAGE LDS Sample buffer (4x) Novex NP0007
Pierce Fast Semi-Dry Transfer Buffer ThermoScientific 35045
MOPS Running Buffer Invitrogen 3324
10x PBS Invitrogen 7757R
4% PFA Roth 664666
Blocking buffer Roth 33285
Target retrieval solution 10x pH6 Dako S1699
Dimethyl sulfoxide Sigma-Aldrich D8418-50ML
cOmplete ULTRA Tablets, Mini, 
EDTA-free,EASYpack
Roche 5892791001
SEA BLOCK Blocking Buffer ThermoScientific 37527
RNaseZap Ambion AM9782
Superscript® II Reverse 
Transcriptase
Invitrogen 100004925
dNTP mix Invitrogen 18427-013
5X First Strand Buffer Invitrogen y02321
0,1M DTT Invitrogen y00147




2.1.4. Cytokines and recombinant proteins
Cytokines used in this study are listed in table 2.4.
Table 2.4: cytokines
2.1.5. Antibodies
Antibodies used in this study are listed in table 2.5.a and 2.5.b
2.1.5.a Primary Antibodies
name company order number
human recombinant TGF-Beta 1 R&D Systems 240-B-010/CF
mM-CSF R&D Systems 416-ML
mGM-CSF R&D Systems 415-ML
IL4 Immunotools 77675
IFN-gamma R&D Systems 240-B-01890
TNF-alpha R&D Systems 240-B-010CF
IL1-Beta R&D Systems 240-B-0798A
epitope company Order number use
Actin abcam ab8227 WB
CD31 abcam ab28364 WB, IF
a-SMA Sigma Aldrich A5228-200UL WB, IF
PECAM1 DB Pharmingen 553370 IF
Snail Cell Signalling ab180714 WB
iNOS Thermoscientific PA3-030A WB
MHCII abcam ab25259 (WB, IF)
Notch 1 abcam ab52627 WB
NICD abcam ab8925 (WB, IF)
Jagged 1 abcam ab7771 WB
CD11b abcam ab8878 IHC
F4/80 Cell Signalling MCA497R IHC,IF,IcF,FACS
Col1A1 abcam ab34710 IF




Table 2.5.a: primary antibodies
2.1.5.b Secondary Antibodies
Table 2.5.b: secondary antibodies
2.1.6. Primers




Cell Signalling 9587S IF
Twist Millipore ABD29 IF




epitope company Order number use
Alexa Fluor ® 488 donkey 
anti-rabbit
Life technologies A21206 IF
Alexa Fluor ® 488 donkey 
anti-rat
Life technologies A21208 IF
Alexa Fluor ® 647 goat anti-
mouse
Life technologies A21235 IF
Alexa Fluor ® 568 donkey 
anti-rabbit
Life technologies A11042 IF
Alexa Fluor ® 488 donkey 
anti-mouse
Life technologies A21202 IF










mSnailF CCACGCTAATGTGTCAACACGA Primer Design
mSnailR AATCGATGCCTGGATTCCAAG Primer Design
mSlugF GCTGTGTACCAGGTAGCTGAC Primer Design
mSlugR GGCCTCCCATCTCCTTCAAT Primer Design
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mActa2F CACTATTGGCAACGAGCGC Primer Design
mActa2R CCAATGAAGGAAGGCTGGAA Primer Design
mCol1a1F ATGGATTCCCGTTCGAGTACG Primer Design
mCol1a1R TCAGCTGGATAGCGACATCG Primer Design
























































MGAPDH_F TGTAGACCATGTAGTTGAGGTCA Dr. Fouzi Alnour





The commercial kits used in this thesis are listed below in Table 2.7.
Table 2.7: kits
2.1.8. Equipment
The equipment utilised in this study is listed in table 2.8.
Table 2.8: equipment
Kit Provider order number
Pierce BCA Protein Assay Kit Thermo Scientific 23225
PureLink RNA mini Kit Ambion (Life Sciences) 12183025
Vectastain Universal Elite ABC kit Vector Laboratories 99585
 ELISA Kit for TGF-Beta Cloud-Clone Corp CEA218Mu
Function Instrument Company
Cell line tissue culture S1 BIOWIZARD KOJAIR
Cell Culture Centrifugation ROTOFIX 32 A Hettich
RNA concentration measurement NanoDrop 2000 ThermoScientific
Heating Block Thermomixer Comfort Eppendorf
Cell Culture Incubator S1 InCu safe EWALD
Primary Cell Culture Incubator S1 NU-543-400E tecnomara
Cell Culture Incubator S2 EWALD
Bright Light Microscopy BX43 OLYMPUS
Protein Electrophoresis Xcell SureLock Electrophoresis Cell Invitrogen
Protein Semi Dry Blotting Fastblot B44 Biometra
RealTime Q-PCR StepONePlus Real-Time PCR 
System
Applied Biosystems
Vortexing Vortex Genie Bender & Hobein AG




2.2.1. Cell culture experiments
2.2.1.1. Culture of MCECs
Immortalised Mouse Cardiac Endothelial Cells (MCEC) were purchased from Cedarlane Labs. 
MCECs consist of microvascular endothelial cells derived from neonatal murine hearts, that have 
been immortalised by lentiviral infection with large sv40 antigen and human telomerase. MCECs 
retain typical endothelial properties by showing contact inhibition, growing on a monolayer and LDL 
uptake, and expressing endothelial cell specific proteins such as VE-cadherin, PECAM-1, 
Willenbrand factor and others like Laminin and ß-catenin in intercellular regions. Cells were 
generally cultured in Endothelial Growth medium, consisting of DMEM supplemented with 1% of 
HEPES and 5% of Fetal Calf Serum. Cells were cultured under 21% of O2 and 5% of CO2 
conditions (152).
2.2.1.2. Generation of macrophage cell lines
2.2.1.2.1. Murine peritoneal Macrophages (PMs)
PMs were harvested from the peritoneal cavity of 10-12 weeks old wild type BL6/N mice (Charles 
River). The adapted protocol, kindly provided by Prof. Von Vietinghoff, consisted of euthanising the 
mice by cervical dislocation of anaesthetised animals and opening a small incision on ethanol-
disinfected skin on the centre of the abdomen, followed by an injection of 5 ml of ice-cold PBS 
inside the peritoneal cavity. After applying a gentle abdominal massage to detach cells, PBS was 
collected with a syringe. Thereafter, PBS containing peritoneal cells was handled under cell culture 
sterile conditions and centrifuged at 100g for 10 min. Cell pellets were resuspended in DMEM 
supplied with 10% of Fetal Call Serum (FCS) and 1% of antibiotics Streptomycin and Penicillin. 
Cell suspension was counted using a Neubauer chamber and cells were typically seeded in 12-
well plates at approximately 1 x 106 cells per ml of medium. Typically, total of cells harvested from 
PBS peritoneal lavages have a composition of B cells (60 %), macrophages (40%) and T cells 
(less than 10 %). In order to enrich macrophages titre, total cell suspension is allowed to adhere on 
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plate for 1 hour at 37ºC, and non adherent cells are removed by gently washing three times with 
culture medium, increasing macrophage count by 90% (153).
2.2.1.2.2. Murine Bone Marrow Derived Macrophages (BMDMs)
Bone marrow cells were flushed in basal DMEM media from tibias and femurs of 10-12 weeks old 
wild type BL6/N mice, following standard procedures. To avoid clumps, DMEM containing cells 
were collected through a 70 µm strainer and in order to get rid of erythrocytes, all cells were 
treated with blood cell lysing buffer for 3 minutes at room temperature. Next, remaining cells were 
plated in 10 % FCS DMEM supplemented with L-Glutamine (2 mM) and  beta-mercaptoethanol (50 
μM) overnight in standard tissue culture treated dishes. Following overnight incubation, 
supernatants were collected and mesenchymal cells attached to tissue culture plates were 
discarded. Supernatants containing macrophage progenitors were counted and spread in suitable 
amount of plates (5-8 x 106 cells per plate) for differentiation in plastic bacteriologic dishes in 
growth medium DMEM supplemented with 10% FCS, L-glutamine and beta-mercaptoethanol and 
in the presence of differentiating cytokines GM-CSF (1000 U/ml) or M-CSF (25 ng/ml) to generate 
GM-BMDM and M-BMDM, respectively. Fresh cytokines were added every 3 days. At day 7, 
differentiated macrophages could be re-plated at a concentration of 5 x 105 cells per ml of medium 
 31
Figure 2.1. Depiction of BMDMs differentiation protocol. Femurs and tibias are extracted from 
euthanised BL6/N mice (A). Whole bone marrow cells are flushed and kept in culture in bacteriological 
dishes overnight (B). Non adherent cells are collected (in purple), while proliferating fibroblast-like cells, 
mature mononuclear phagocytes, and other stromal cells adhering to the flask (in green) are discarded (C). 
Macrophage progenitors are cultured for 7 days in GM-CSF and M-CSF (D). At the 7, they have acquired 
spread and spindle shape morphology and differential expression of pro-inflammatory and anti-






for assay. Cells were cultured in 21 % O2 and 5 % CO2. Cells were subcultured using Accutase. 
For macrophage activation, 50 ng/ml of E.Coli derived lipopolysaccharide (LPS) was added to 
growth medium for at least 6 hours.
2.2.1.2.3. RAW 264.7 cell line
RAW 264.7 cells were a kind gift from Prof. Dr. Katschinski and Prof. Dr. Raaz. RAW 264.7 cells 
are immortalised murine cells derived from Abelson virus leucemic mice. RAW were grown in 10 % 
FCS DMEM and were subcultured by scraping. Cells were cultured in 21 % O2 and 5 % CO2. For 
polarisation, RAW 264.7 cells were treated in growth medium with IL-4 (20 ng/ml), IFNγ (100 ng/
ml) or IFN-γ (100 ng/ml) and LPS (50 ng/ml) combined for the indicated times in normal growth 
culture.  Native controls were treated with PBS.
2.2.1.3. Culture of control cell lines
2.2.1.3.1. Mouse Cardiac Fibroblasts (MCFs)
MCFs were purchased from ScienCell (#M6300-57). MCFs are neonatal murine cardiac fibroblasts 
and were used at passage number 5-10. Cells were subcultured in growth FM2 medium according 
to the manufacturer instructions on poly-Lysine coated tissue culture plates at 5 % CO2 and 21% 
O2 conditions. To activate fibroblasts, MCFs were first starved overnight in basal FM2 medium and 
then treated with human recombinant TGF-ß 1 at 10 ng/ml in basal FM2 medium.
2.2.1.3.2. HeLa
HeLa cells were a gift from Prof. M. Zeisberg. HeLa cells are adenocarcinoma epithelial cells that 
divide indefinitely and are widely used for mechanistic assays and cancer research due to their 
straight forward handling. HeLa cells were grown in 10 % FCS, low glucose DMEM at 5 % CO2 
and 21% O2 conditions.
2.2.1.3.3. C2C12 cells
C2C12 cells were a kind gift from Prof. S. Lehnart. C2C12 cell line is a murine skeletal myoblast 
cell line derived from satellite cells from the thigh muscle of C3H mouse strain. It divides 
indefinitely and differentiates rapidly to myocytes, forming contractile tubes and muscle proteins 
(151). Although differentiation protocol requires horse serum and insulin supplements, C2C12 cells 
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can differentiate easily upon cell-cell contact (154). Cells were maintained in DMEM supplemented 
with 10 % FCS and Glutamax™ and subcultured by trypsinizing followed by dilution in a 1:30-1:60 
factor. For co-cultures, cells were seeded at minimum density of 5x10^3 cells/ml, termed as “low-
C2C12” or at high density of 5x10^5 cells/ml, termed as “high-C2C12”.
2.2.1.3.4. MCT cells
MCT cells were a kind gift from Prof. M. Zeisberg. MCT cells are a differentiated, SV40 
transformed cell line originally derived from SJL mice. MCT cells are well characterised functional 
proximal tubular epithelial cells. Cells were grown under standard conditions in 10 % FCS DMEM 
and at a cell culture chamber at 5 % CO2 and 21% O2.
2.2.1.3. TGF-ß induced EndMT
To induce classical EndMT, MCECs were subcultured and plated at a density of 30-40 % 
confluence in endothelial growth medium. When attached to plate and after acquiring normal 
morphology, growth medium was replaced by reduced serum medium, containing 1 % FCS, and 
cells were incubated overnight. At the following day and until experiments were finished and unless 
otherwise indicated, human recombinant TGF-ß 1 was added to serum reduced medium every day 
at a concentration of 10 ng/ml of medium.
2.2.1.3. Conditioned medium (CM) experiments
2.2.1.3. 1. Macrophage-derived CM
Conditioned medium (CM) from GM-BMDM and M-BMDM was generated by plating differentiated 
macrophages at a density of 1x106 cells/ml on standard tissue culture wells. For activated 
macrophages, LPS was added to GM-BMDMs and M-BMDMs at 50 ng/ml and allowed to incubate 
for 1 hour. For control unstimulated cells, equivalent amount of vehicle (PBS) was added. After 
stimulation, medium containing LPS was discarded and cells were washed extensively by washing 
three times with PBS and two times with basal DMEM medium. Thereafter, basal medium was 
added and remained in incubation with cells for at least 48 hours. After incubation, CMs were 
collected, centrifuged and filtered through a 0,22 µm filter to remove debris and either were 
immediately used for assay or were snap frozen in liquid nitrogen and stored at -80ºC. CMs were 
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applied on MCECs cells that were previously serum starved in DMEM overnight at 1:1 (v/v) with 
basal DMEM or grown in complete CM. Negative control was assayed using basal DMEM. Positive 
control was tested using basal DMEM and TGF-ß 1 at 10 ng/ml. When indicated, CMs were 
supplied with TGF-ß 1 at a final concentration of 10 ng/ml for further analysis.
2.2.1.3. 2. Endothelial-derived CM
Native endothelial derived CM were generated by plating MCECs at 60-70 % confluence and 
incubating cells for 24 hours in basal DMEM supplemented with 1 % of HEPES. After incubation, 
CM was collected and filtered as previously described. 
EndMT-derived CM was generated by inducing EndMT in MCECs with TGF-ß1 as indicated earlier. 
After 48 hours of TGF-ß 1 treatment, cells were extensively washed, three times with PBS and two 
times with basal DMEM, and basal serum supplemented with 1 % of HEPES was applied. After 24 
hours of incubation, EndMT-CM was collected, filtered, and used for assay or stored at -80ºC.
native-MCEC and EndMT-MCEC derived CMs were applied to RAW 264.7 macrophages at 1:1 (v/
v) with RAW growth medium for 24 hours. Negative controls consisted of endothelial basal DMEM 
(1  % FCS) mixed with RAW 264.7 growth medium.
2.2.1.3. 3. Co-culture-derived CM
Conditioned medium from co-cultures was collected by recovering supernatants from co-cultures of 
BMDMS and MCECs after 48 hours of cell co-culture (procedure explained below). CMs were 
harvested and filtered and stored or applied to serum-starved MCECs following the same protocol 
than macrophage-derived CM application.
2.2.1.4. Bidirectional paracrine co-culture experiments
MCECs were plated in serum reduced DMEM on Transwell® (Costar®, #3460) porous inserts at 
40 % confluence. BM-BMDMs and M-BMDMs were plated at a density of 5 x 105 cells/ml beneath 
transwell® inserts containing MCECs. Macrophages were allowed to attach overnight before 
applying MCECs on co-culture insert. Co-cultures were allowed to grow for 48 hours. In parallel, 
mono-cultures (negative controls) of MCECs, M-BMDMs and GM-BMDMs were plated under the 
same conditions in serum reduced endothelial medium. A positive control was added in which 
MCECs were treated in mono-culture with TGF-ß 1.
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2.2.1.5. Juxtacrine co-culture experiments
In order to study contact dependent cell-cell interactions, MCECs and macrophages were co-
cultured together in the same culture plates. An orange fluorescent live cell tracker CMTMR was 
utilised to track one of the cell populations, to be able to sort them conveniently on downstream 
operations through fluorescence activated cell sorting (FACS). According to manufacturers 
instructions, CMTMR fluorophore remain vividly fluorescent for at least 72 hours after incubation in 
fresh medium at 37ºC and through at least four cell divisions. In our hands, cells lost fluorescence 
at 72 hours of co-culture (Figure 2.2. A), which hindered the efficient separation process of distinct 
populations. For this reason, co-cultures were collected 48 hours after tracker application. No 
detrimental effects on proliferation and plating efficiency of stained cells were observed, and 
leakage from one cell population to the other was never observed, consistent with previous reports 
(155,156). No significant changes upon TGF-ß stimulation were found in MCECs treated with 
CMTMR (Figure 2.1 B). Our FACS sorting isolated a 97-99 % pure population (assessed by BC 
FACS Diva 5.0 software) which was checked by FACS and fluorescence microscopy (Figure 2.1 
C).
MCECs were loaded with CMTMR tracker by incubating confluent adherent cells with 10 µM of 
CMTMR diluted in basal DMEM for 45 min at 37 ºC in a cell culture incubator. After tracker loading, 
tracker solution was discarded and cells were washed, trypsinized and subcultured for 
experiments. Generally, MCECs were plated at 40 % confluence on standard 6-well plates. After 1 
hour, unstained cells (either macrophages or control cells) were added to stained cells. For mature 
BMDMs, M-BMDM and GM-BMDM were either vehicle treated or LPS-stimulated. 1 hour after 
stimulation, BMDMs were extensively washed and subcultured at 5x105 cells/ml on plates 
containing CellTracker stained MCEC cells. Contact co-cultures were sustained for 48 hours. After 
incubation, cells were detached and prepared for FACS sorting. For RAW 264.7 co-cultures, 





Figure 2.2. CMTMR live fluorescent staining. A) Representative cytometry analysis of unstained cells 
(left), cells stained after 48h (middle) and cells stained for 72h (right). B) RT-qPCR analysis of EndMT 
marker genes in unstained MCEC cells (“control”, “TGF-ß1”) and stained (“CMTMR”, “CMTMR +TGF-ß1”). 
C) Left, fluorescent microscopy of stained MCEC cells. Right, bright field microscopy and fluoresce 







































All experimental animal studies were performed with the approval of the Institutional Animal Care 
and Use Committee of the University Medical Center Göttingen. All surgical animal procedures 
were performed by specifically trained staff of the Zeisberg group.
2.2.2.1. AAC model
Ascending aortic constriction was performed in 12-week-old mice under anesthesia with a mixture 
of ketamine (100 mg/kg) and xylazine (10 mg/kg) given at 0.1 ml intraperitoneally as described 
previously (56). Adequacy of anesthesia was monitored by observing muscle twitch and by tail 
pinch as well as documenting heart rate and body temperature. As postoperative analgesia, 
Buprenex (0.1 mg/kg) was given intraperitoneally every 6–8 h for the first 48 h. All mice used 
weighed 25–30 g. For sham control operated mice, the chest was surgically opened under the 
same conditions as banded mice except that no aortic banding was performed. 4 weeks after 
operation, mice were sacrificed with a lethal intraperitoneal dose of pentobarbital sodium (100 mg/
kg) followed by cervical dislocation.
2.2.2.2. Ang II model
Angiotensin II model was performed as described (156). Briefly, 2 mg/kg per day of Ang II was 
administered by implantation of osmotic minipumps (ALZET osmotic minipumps; type 2ML4) for 14 
days. At the end of the experiment, echocardiography was performed under 2-4 % of isofluorane 
anaesthesia. 
2.2.2.3. ApoE -/- model
Frozen sections of aortas from Apolipoprotein E deficient mice were used in collaboration with Prof. 
Von Vietinghoff (Hannover University) and PhD student Alexandra Helmke. Apo E Mice were 
generated as described (157). Both wild type and ApoE-/- strains (both with C57BL/6 background) 
were fed during 12 weeks with high-fat diet (HFD) containing 40 % kcal from fat and 1.5 % 
cholesterol. Animal experiments were approved by the Animal Care Committee at La Jolla Institute 




2.2.3. Molecular Biology techniques
2.2.3.1. RNA isolation and Real Time Quantitative-PCR 
Total RNA was extracted from cells using PureLink RNA kit following the manufacturer's protocol.
1μg of total RNA was digested with DNase I (Sigma) and used for cDNA synthesis using the 
SuperScript II system (Life Technologies). Diluted cDNA (1/10) was used as a template in Fast 
SYBR Master Mix (Life Technologies) and run on a StepOne Plus realtime PCR system with the 
real-time specific PCR primers (sequences are listed in Table 2.6.). Measurements were 
standardised to GAPDH or HPRT using delta delta Ct standard methodology.
2.2.3.2. Immunoblotting
2.2.3.2.1. Protein extraction
Proteins were extracted from cells using NP40 lysis buffer (Life technologies), containing protease 
inhibitor cocktail (Roche). Cell were lysed by resuspending cell pellet in adequate amount of lysis 
buffer (usually 100 μl per 6-well plate dish), and cell suspensions were incubated at 4 ºC per 30 
min in a rotating system. Thereafter, lysate suspension was centrifuged at maximum speed in a 
tabletop centrifuge at 4 ºC. After centrifugation, supernatant was collected and assayed for protein 
content measurement using BCA Kit (ThermoScientific). After protein concentration determination, 
samples were stored at -80 ºC or used for sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE) 
electrophoresis. 
2.2.3.2.2. SDS-PAGE electrophoresis
Protein samples were diluted till concentration of 1μg/μl and 15-20 μl were used per sample in a 
mixture with SDS-loading buffer (25%) and beta-mercaptoethanol (10%) in a SDS-PAGE gel 
pocket. Equal amounts of protein were loaded in each pocket. Samples were then resolved on 
4-12 % SDS-PAGE (Novex, Invitrogen) at 80-120 mV.
2.2.3.2.3. Western Blot
 After proteins were resolved, proteins contained in gel were transferred onto a nitrocellulose 
membrane (Amersham Biosciences) using a semi-dry protein transfer system (Biometra). Protein 
transfer was efficiently accomplished by using 150 mA for 15 min followed by 250 mA for 45 min. 
Thereafter, membrane was blocked by incubating it for 1 hour at room temperature with a blocking 
buffer of tris-buffered saline (TBS), Tween 20 (0,1%) and non-fat milk (5%) at pH 7.2. After 
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blocking, the membrane was incubated overnight at 4ºC with primary antibodies in an adequate 
dilution (1:500-1:5000) of antibody (primary antibodies are listed in table 2.5. a) in TBST  buffer 
supplemented with  2% non-fat milk.
2.2.3.2.4. Protein detection 
On the second day, after washing three times for 10 min with TBST, the membrane was incubated 
with secondary HRP-conjugated antibodies (listed in table 2.5.b) diluted in TBST and 2% non-fat 
milk during 45 min at room temperature. Secondary antibody excess was removed by washing 3 
times for 10 min with TBST . Finally, antibody signals were detected using a chemiluminescent kit 
and visualisation was made in a Bio-rad camera system.
2.2.4 Immunostaining techniques
2.2.4.1. Immunohistochemistry
Paraffin embedded cardiac tissue sections were prepared by technical assistance employees 
Annika Faust and Sarah Rinkleff. Paraffin embedded tissue sections were deparaffinized by 
incubation with Xylol for 10 min, two times. Next, gradual dilutions of ethanol (100%-30% ethanol) 
were applied to sections for 30 min until final incubation with distilled H2O at room temperature. 
After washing with PBS two times, sections were treated with pH 6 citrate buffer for 40 min in a 
steam bath. Afterwards, sections were blocked with 0.3 % peroxidase buffer for 30 min at room 
temperature. Thereafter, samples were blocked with bovine serum albumin (BSA) 2 % in 
phosphate buffered saline (PBS) and primary antibody was applied and let overnight for incubation 
at 4 ºC. The next day, excesses of antibody were removed by gently washing three times with 
PBS. After washing, a specific secondary antibody from Vectastain Universal Elite ABC commercial 
kit was applied following the manufacturer’s protocol. Sections were then analysed at a bright field 
microscope. 
2.2.4.2. Immunofluorescence of Paraffin sections
Paraffin embedded cardiac tissue sections were prepared by technical assistance employees 
Annika Faust and Sarah Rinkleff. Sections were deparaffinized as explained previously. Thereafter, 
antigen retrieving was accomplished by using citrate buffer in a warm steam bath for 40 min. 
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Afterwards sections were blocked with a PBS buffer containing BSA 2 % for 30 min and first 
antibody was applied in blocking solution overnight at 4 ºC. The day after, sections were washed 3 
times with PBS and secondary antibody was applied in blocking solution at a dilution of 1:400 and 
incubated for 45 min. Next, secondary antibody excess was removed by washing with PBS 3 times 
for 5 mins, and DAPI staining was applied. Sections were then mounted and dried for one hour. 
Samples were then ready to visualise in confocal or conventional fluorescence microscope.
2.2.4.3. Immunofluorescence frozen sections (aortas)
Frozen aortic tissue sections were prepared by AG Von Vietinghoff group at Hannover Medicine 
University. Frozen tissue sections were air dried for 10 mins and fixed with 100 % methanol for 9 
minutes. Thereafter, equal immunofluorescence protocol than paraffin-embedded sections was 
applied.
2.2.4.4. Immunocytofluorescence
For immunofluorescence analysis, cells were grown in polystyrene chamber slides (Falcon). When 
experiment was finished, chambers were removed from slides and slides were washed in PBS 
briefly. Next, cells were fixed by using ice-cold methanol (100%) for 9 min. Thereafter, for 
intracellular protein detection, cells were permeabilised by using PBS containing Triton 0, 1% for 
10 min at room temperature. Next, blocking step was followed by incubating slides with 2% BSA in 
PBS or using sea blocking buffer for 30 min at room temperature.  After blocking, primary antibody 
was added in blocking solution and allowed to incubate overnight at 4 ºC. The next day, the same 
protocol as for immunofluorescence tissue sections was followed. 
2.2.5. Fluorescence-activated cell sorting (FACS)
For immunostaining of adherent cells, cells were trypsinized, centrifuged and resuspended in 2 % 
BSA in PBS to a final concentration of 106 cells/ml. After blocking in 2 % BSA for 10 minutes, 
fluorescence-labelled antibody was applied to cell suspension and incubated for 60 min at 37 ºC in 
a cell incubator. Thereafter, cells were washed three times by adding blocking buffer and 
centrifuging the cell suspension. Afterwards, cells were resuspended in adequate amount of 




Analysis of variance was used for multiple comparisons of groups to determine significance. A 
Student t test analysis was used for the single-parameter comparisons. Statistical significance was 





3.1. Cardiac macrophages are increased in cardiac disease
3.1.1. Macrophage numbers are increased in human myocardial fibrosis
Macrophages have not been of great interest for cardiologists in the past, probably due to an only 
small incidence of infective diseases in the heart. The increasing knowledge unveiling that 
pathogenesis of atherosclerosis involves a complex maladaptive immune response brought the 
attention of immunology to the cardiology field. Still, although progress has been made, data of 
macrophage abundance in human cardiac disease is quite limited to myocardial infarction (160). 
Because cardiac fibrotic onset and progression extend beyond fibrotic remodelling as a result of 
acute cardiac ischemia and nowadays we know that extensive fibrosis occurs in a wider range of 
cardiac pathologies, we examined macrophage content in patients with cardiac fibrosis of different 
backgrounds. We examined macrophage specific marker CD68 in cardiac tissue samples from 
patients with aortic stenosis, diabetic cardiomyopathy and myocardial infarction, and we compared 
these to healthy controls derived from individuals that had suffered sudden death (meaning that 
they were allegedly healthy individuals before time of death) (Figure 3.1). Human CD68 is a heavy 
glycosilated transmembrane protein that is expressed in the endosomal-lysosomal system in the 
cytoplasms of the monocyte/macrophage myeloid lineage. CD68 is widely used as a broad pan-
macrophage marker, and there is extensive literature of its use for identification of macrophages in 
diverse cardiovascular pathologies such as atherosclerosis, chronic inflammation, and also in the 
ischemic heart (161-163). CD68 antibody stained elongated and rounded cells with a granular and 
sometimes defused red cytoplasm staining in the examined cardiac tissue specimens (Figure 3.1 
A-D). CD68-positive cells localised around the vessels and scattered through the myocardium in 
the intercellular space between cardiomyocytes. In diseased patients, numerous CD68-positive 
cells accumulated in fibrotic regions, encapsulated within, and accumulated in perivascular areas. 
Importantly, the macrophage number was significantly higher in diabetic cardiomyopathy, aortic 
stenosis, and myocardial infarction derived tissue samples than in healthy control samples (Figure 
3.1, I) . Aortic stenosis (AS) is a condition that as a result of age, calcification or congenital 
disease, leads to aortic valve constriction that eventually results in left ventricle hypertrophy and 
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myocardial fibrosis (164). Fibrosis derived from AS is typically associated with perivascular fibrosis, 
caused by the excessive blood pressure overload (165). Coincidently, macrophage accumulation 
was the highest in AS cardiac tissue, and these macrophages mostly accumulated in the fibrotic 
region surrounding the vessels. Diabetic cardiomyopathy is also associated with extensive 
perivascular fibrosis and mild interstitial fibrosis. Our data shows that diabetic patients also have an 
increase in macrophage count. Furthermore, analysis of the infarcted samples revealed a 
significant increase of CD68-positive cells at the remote zone of the infarcted myocardium. Overall, 
we observed macrophages in all cardiac tissues examined and a found significant number 
increase in all pathological tissues.
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Figure 3.1. Macrophages are increased in 
h u m a n c a r d i a c fi b r o t i c d i s e a s e . 
Immunohistochemistry representative images of 
cardiac tissue specimens of human pathologies 
aortic stenosis (B), diabetes (C) and myocardial 
infarction (D), compared to healthy controls (A) 
(400x). Representative Masson trichrome staining 
images are presented below (E-H). Scale bars 
represent 200 μM.  Quantitative data analysis of 
patient samples compared to control is presented 
as mean and SEM (I and J). n=6 per group in 
CD68 staining, and n= 12  for overall fibrosis 
quantification. * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 
0.001, **** P ≤ 0.0001.
Aortic StenosisControl Myocardial InfarctionDiabetes









3.1.2. Macrophage numbers are increased in murine models of cardiac 
fibrosis
Next, we investigated the content of murine macrophages in models of murine experimental 
cardiac fibrosis. We utilised Angiotensin II (Ang II) and ascending aortic constriction (AAC) models 
of cardiac fibrosis, which despite a different physiological approach, both succeed to induce robust 
cardiac fibrosis in mice (Figure 3.2, A-B and Figure 3.3, A-C). Angiotensin II is a pro-fibrotic protein 
and the central product of the renin-angiotensin system, a signalling pathway known to play a 
central role in cardiac and renal pathophysiological processes. The production of Ang II by this 
pathway, is known to cause potent increases in systemic and local blood pressure due to its 
vasoconstrictive effect (166). Ang II interferes directly with the cardiovascular system and induces 
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Figure 3.2. Macrophages increase in Angiotensin II murine heart. Immunohistochemistry 
representative images of paraffin sections of Angiotensin II murine myocardium showing expression of 
CD11b marker in vehicle control (C) and Angiotensin II treatment (D), and F4/80 macrophage marker in 
vehicle control (F) and Angiotensin treatment (G). Summarised quantitative findings are showed as means 
+ SEM of 4 animals per group (E and H). *** P ≤ 0.001, **** P ≤ 0.0001. Ang = Angiotensin II. Scale bars 
represent 100μm.
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vasoconstriction, cardiac hypertrophy, aortic aneurysms, atherosclerosis and myocardial fibrosis 
(166-168). Moreover, Ang II has pro-fibrotic effects alone in vitro. Pharmacological inhibition of the 
Angiotensin/Renin system by Ang II receptor blockers has beneficial effects in preventing 
cardiovascular maladaptive remodelling and CF. Osmotic pumps loaded with Ang II were implanted 
in mice at a pathophysiological concentration of 2.0 μg/kg/min for 14 days; a time point in which 
signs of fibrotic deposition were notable (Figure 3.2., B). We found that Ang II-treated myocardium 
was heavily invaded with macrophages, as indicated by immunohistochemistry staining of specific 
macrophage markers F4/80 and CD11b (Figure 3.2. C-G). Vehicle (saline) control mice also 
showed expression of myeloid cells (consistent with other reports showing a substantial amount of 
macrophages in the steady-state murine heart) (169), albeit to a much lesser extent than Ang II 
treated mice. F4/80 and CD11b staining patterns were associated with elongated cells located in 
the interstitial space between cardiomyocytes in fibrotic hearts, while F4/80- and CD11b-positive 
cells in control mice acquired a more rounded shape. Similarly, we found that AAC operated hearts 
harboured a significantly enhanced population of F4/80-positive and CD11b-positive cells as 
compared to sham control hearts (Figure 3.3., D-I). The AAC model is the murine analog of human 
aortic stenosis, and it is achieved by surgical constriction of the ascending aorta, which leads to 
pressure overload of the left ventricle and subsequent development of cardiac hypertrophy and 
myocardial fibrosis. In contrast to other reports showing that macrophage levels are reduced to 
almost baseline levels 21 days after TAC (170) (Transverse Aortic Constriction, a similar procedure 
that also induces pressure overload) (171), our findings show that 14 and 28 days post AAC 
operation, accumulation of macrophages remain significantly increased (Figure 3.3 J, K). This may 
be due to surgical differences between TAC and AAC models; where TAC involves a constriction of 
the transverse aorta at the aortic arch, AAC consists of banding of the ascending aorta section, 
closer to the heart. The AAC model results, in our experience, in a more robust and earlier 
manifestation of fibrosis, and this may result as well in a longer sustained inflammation compared 




Figure 3.3. Macrophage number increases in AAC murine heart. Immunohistochemistry representative 
images of paraffin sections of fibrotic AAC mice showing MTS staining of SHAM (A) and AAC operated 
animals  2 weeks and 4 weeks after operation (B and C, respectively). Below, expression of CD11b marker 
in control SHAM operated animals(D) and AAC operated 2 and 4 weeks after operation (E and F), and 
F4/80 macrophage marker in SHAM (G) and AAC operated mice 2 and 4 weeks after operation (H and I, 
respectively). Summarised quantitative findings are showed as means + SEM of 6 animals per group (J 
and K). Scale bars represent 100 µm. P values correspond to ** P ≤ 0.01, *** P ≤ 0.001, between sham 
and AAC groups, calculated using non-parametric t-test analysis. AAC = ascending aortic constriction 
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3.1.3. EndMT occurs in atherosclerotic ApoE-deficient mice
Atherosclerotic lesions are great examples to explore the object of study in this thesis: they 
represent a local environment where endothelial damage, high inflammatory and fibrotic mediators 
and maladaptive macrophage accumulation come together (157). In the atherosclerotic plaque, 
accumulation of monocytes and macrophages are associated with a focal chronic inflammatory 
process that leads to necrosis and fibrous cap thinning in advanced atherosclerotic disease (173). 
For identification of endothelial cells undergoing EndMT in atherosclerosis, tissue sections from 
aorta roots of ApoE-deficient mice were analysed using confocal microscopy. The ApoE deficient 
mouse is a widely used atherosclerotic mouse model that spontaneously develops atherosclerotic 
lesions, which are accelerated upon a high fat diet (HFD). This is because ApoE functions as a 
ligand of members of the low-density lipoprotein receptor (LDLR) family that clear chylomicrons 
and very low–density lipoprotein remnants. ApoE is also synthesised by monocytes and 
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Figure 3.4. EndMT occurs in murine atherosclerosis. Confocal 
microscopy images showing areas in proximity with 
atherosclerotic lesions at the aorta root of 12 weeks High Fat Diet 
(HFD) fed wild type mice (Apo E +/+) vs Apolipoprotein E deficient 
mice (Apo E -/-). A) Double fluorescence staining for endothelial 
cell marker CD31 (red), mesenchymal markers ɑSMA and Col1A 
and transcription factor Twist (in green). Nuclei are shown with 
DAPI staining (blue) B) Close-up confocal microscopy image of 
cells undergoing EndMT, double stained for CD31 (red) and ɑSMA 
(green). Nuclei are shown in DAPI (blue). Summarised 
quantitative findings of double positive CD31/ɑSMA cells and 
CD31/Twist cells are shown as means + SEM of 3 animals per 





















macrophages in vessels, and is thought to have local effects on cholesterol homeostasis and on 
inflammatory reactions in atherosclerotic vessels (174).
Because occurrence of EndMT has already been shown elsewhere (71,72) and since endothelial 
cells in atherosclerosis are exposed to an extensive inflammatory environment fuelled by 
macrophages, we hypothesised that atherosclerotic macrophages were associated with EndMT. 
We found cells co-expressing endothelial marker CD31 and mesenchymal markers α-SMA and 
Collagen I in atherosclerotic plaques of ApoE- HFD- fed mice. We found that the amount of double-
positive cells was significantly higher in ApoE-deficient mice compared with wild type HFD fed 
control group (Figure 3.4.). We also found enhanced expression of EndMT transcription factor 
Twist in ApoE deficient mice. We found that CD31/Twist double positive cells and CD31/α-SMA 
double positive cells were increased in ApoE mice compared to wild type (Figure 3.4 C and D). 
Interestingly, we also found Twist highly expressed in cells negative for CD31 adjacent to the 
endothelium. Furthermore, we stained macrophages with F4/80, CD68 and CD11b antibodies, and 
found that macrophages localised in close contact with endothelial cells (Figure 3.5).
 48
Figure 3.5. Macrophages are located in the vicinity of the endothelium. Accumulating macrophages in 
atherosclerotic aortas interact with endothelial cells. Representative confocal microscopy images show 
areas in proximity with atherosclerotic lesions of 12 weeks HFD fed wild type mice (Apo E +/+). A) Triple 
staining with CD31, a-SMA and macrophage marker F4/80. B) Macrophages are shown stained for CD68 
(green). C) CD11b positive cells (green) interact closely with endothelial cells, positive for CD31 
(red).Nuclei are shown wit DAPI staining (blue). L= lumen
L




3.2. Inflammatory cytokines TNF-α and IL-1ß induce EndMT in MCECs.
In order to develop an effective in vitro EndMT system for this study, we chose an immortalised 
mouse cardiac endothelial cell line (MCECs) as a suitable murine in vitro tool, compatible with the 
following experiments using murine macrophage cell lines. In order to establish experimental 
canonical EndMT induction in MCECs, we treated MCECs with TGF-ß1 at different concentrations 
(1 and 10ng/ml) for 1, 2 and 4 days. We found the strongest and most consistent induction of 
EndMT transcription factors (Snail, Slug and Twist) and mesenchymal marker gene Acta2 using a 
concentration of 10ng/ml of human recombinant TGF-ß1 during 2 days of treatment (Figure 3.6., A 
and B). This was reflected at the protein level with a decrease of the endothelial marker CD31, and 
an increase of the EndMT transcription factor Snail and the mesenchymal protein alpha-SMA 
(Figure 3.6., C). TGF-ß1 treatment for 4 days was associated with a morphological change (Figure 
3.6, D), in which endothelial cells showed a more elongated and spindle-shaped appearance, 
typical of migrating mesechymal-like cells. 
Next, due to their known potential as EndMT inducers (117,118), we treated MCECs with 
inflammatory cytokines TNF-α and IL-1ß, to examine whether MCECs were inflammation-
responsive and capable of undergoing EndMT in these conditions. Both TNF-α and IL-1ß were 
able to stimulate expression of Acta2, and Fsp1 (also known as S100a4) expression although 
considered a modest induction compared to TGF-ß induced-EndMT (Figure 3.7). When comparing 
both inflammatory cytokines, TNF-α was the strongest inducer.
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Figure 3.7. Inflammatory cytokines TNF-α and IL-1ß promote mesenchymal phenotype in MCEC. 
RTq-PCR analysis of EndMT relevant genes upon TGFß-1(10ng/ml), TNF-α.(100ng/ml) and IL-1ß(20ng/
ml). Results are shown as means + SEM of triplicate determinants and are representative of two 
independent experiments (n=2). * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, **** P ≤ 0.0001.
Results
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Figure 3.6. Mouse cardiac endothelial cells undergo Endothelial-to-Mesenchymal Transition upon 
TGF-ß 1 stimulation. A) RTq-PCR analysis of EndMT marker genes of MCECs after 2 days TGF-ß1 
treatment. B) qRT-PCR analysis of EndMT marker genes of MCECs after 4 days TGF-ß1 treatment. qRT-
PCR results are shown as means + SD of triplicate determinants and are representative of three independent 
experiments. * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, **** P ≤ 0.0001. C) Immunoblot showing protein 
expression of CD31, αSMA and Snail in MCECs upon 4 days of TGF-ß1 treatment. Loading control is shown 
in Ponceau total protein membrane staining. This blot is a representative image of three independent 
















3.3. Phenotype profile of bone marrow-derived macrophages in basal 
and LPS stimulation conditions
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating 
factor (M-CSF) cytokines are known to promote monocyte differentiation into functionally different 
macrophages (175-177,205). GM-CSF gives rise to GM- bone marrow-derived macrophages 
(hereafter termed GM-BMDM) that produce pro-inflammatory mediators upon Toll-like-receptor 
(TLR) stimulation, whereas M-CSF generates M- bone marrow-derived macrophages (M-BMDM) 
with enhanced anti-inflammatory cytokine IL-10 production in response to pathogenic stimuli. 
Lipopolysaccharide (LPS) treatment, either alone or in combination with interferon gamma (IFNγ), 
is considered as the paradigmatic stimulus for acquisition of the classical macrophage polarisation/
activation state. In order to investigate whether macrophages can induce EndMT, we first 
generated polarised macrophages derived from bone marrow progenitors. Murine bone marrow 
cells were cultured in vitro for 7 days in the presence of GM-CSF or M-CSF cytokines and the 
adherent cells (GM-BMDM and M-BMDM) were collected. After day seven of macrophage 
differentiation and polarisation protocol, we confirmed that both populations express common 
macrophage markers CD11b and F4/80 (Figure 3.8. A and B) by FACS and immunofluorescence 
staining. Under basal conditions, GM-BMDM and M-BMDM showed limited but significantly 
different mRNA levels of TNF-α, IL-10 and inflammatory chemokine CCL2. The relative basal 
levels of CCL2 and Interleukin 12 subunit IL12p40 were enhanced in GM-BMDM compared to M-
BMDM (P < 0.01) whereas the relative basal mRNA levels of anti-inflammatory IL-10 were 
enhanced in M-BMDM compared to GM-BMDM (Figure 3.8, C and D). There were no significant 
differences in the basal mRNA levels of IL-6, TNF-α or IL-23 between the two macrophage 
populations. 
E.Coli derived exogenous LPS treatment was used as the pathogen associated microbial pattern 
(PAMP) to stimulate macrophage TLR receptors. Upon TLR stimulation, GM-BMDM produced 
significantly more TNF-α (P < 0.01) and IL-6 (P < 0.01) compared with M-BMDM (Fig. 3.8. C, 
pattern bars). Both IL-12p70 and IL-23 are composed of two subunits, a common p40 subunit and 
either a p35 or a p19 subunit, respectively (176). GM-BMDM secreted IL-23 following LPS 
stimulation whereas M-BMDM failed to do so over a 24-h period. LPS-stimulated M-BMDM and 
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GM-BMDM robustly produced IL-12p40, although M-BMDM at slightly lower levels than GM-
BMDM. In contrast to the above, LPS-stimulated M-BMDM secreted enhanced IL-10 (P < 0.05). 
Taken together, two bone marrow-derived macrophages lineages with differential expression of 
inflammatory and anti-inflammatory mediators were generated.
3.4. Characterisation of macrophage polarisation in RAW 264.7 cells.
In order to obtain distinct inflammatory phenotypes in RAW 264.7 cell line, a murine immortalised 
macrophage cell line, an activation protocol was established using the pro-inflammatory cytokine 
IFNγ, and anti-inflammatory cytokine IL-4, and TLR agonist LPS. RAW 264.7 cells were treated 
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Figure 3.8. Characterisation of GM-BMDM and M-BMDM. BMDM were characterised after 7 + 1 days 
of differentiation protocol. A) Representative flow cytometry analysis graph of F4/80 and CD11b 
macrophage marker expression in BMDMs at day 7 of the differentiation protocol. B) Representative 
immunofluorescence pictures of BMDM expressing F4/80 (95%-99%). C-D) Differential stimulatory 
activity and basal cytokine mRNA expression of GM-BMDM and M-BMDM. Basal (bold graphs, left) and 
LPS stimulated (pattern graphs,right) cytokine mRNA expression in GM-BMDM and M-BMDM as 
measured by qRT-PCR. Levels of CCL2, IL-6,TNF- α, IL-10, IL-12p40 and IL-23p19 mRNA were 
normalised to an endogenous reference (HPRT) and calibrated to the lowest expression level for each 











with either IL-4 (20ng/ml) , IFNγ(100ng/ml), LPS (50ng/ml) or a combination of IFNγ and LPS in a 
time course of 2, 6, 12 and 24 hours. Pro-inflammatory common markers iNOS (inducible nitric 
oxide synthase) and MHCII (major histocompatibility class II) protein levels were found increased 
in IFNγ-RAWs and LPS-RAWs after 24 hours of treatment (Figure 3.9., A), while a modest or no 
increase was observed in IL-4-treated RAW 264.7 cells. Moreover, the morphology drastically 
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IFN + LPSIL4
Figure 3.9. Characterisation and polarisation of RAW 264.7 cells. A) Western Blot showing protein 
expression of activation markers iNOS and MHCII in RAW 264.7 cells after overnight treatment with IL4 
(20ng/ml), IFN-γ (100ng/ml) and LPS (50ng/ml). B) Representative bright field microscopy picture showing 
a differential morphological effect of IL4 and IFN+LPS after 24 hours of treatment. C-G) Stimulatory activity 
and cytokine mRNA expression of RAW 264.7 cells as measured by qRT-PCR. Levels of TNF- α, MHCII, 
IL-6, IL-10 and CCL2 mRNA were normalised to an endogenous reference (HPRT) and calibrated to the 
expression level 6 hours time for each cytokine. Where not visible, error bars are smaller than the symbol. 



















changed upon treatment, leading to round aggregated cells in IL4-RAWs after 24 hours and 
stellated filopodia-forming cells in IFN/LPS-RAWs (Figure 3.9., B). 
When tested for a time response to distinct activators, native, IL-4-, IFNγ- and IFNγ+LPS RAW 
264.7 cells showed a differential expression of MHCII, chemokine CCL2 and cytokines IL-6 and 
TNF-α (Figure 3.8., C-G). IFNγ- and IFNγ+LPS-RAWs showed the highest induction of TNF-α and 
CCL2 (Figure 3.8., C,G) after 6h of treatment, and this induction was enhanced in IFNγ+LPS- 
RAW 264.7 cell line (P < 0.05 IFNγ-RAW versus LPS stimulated IFNγ-RAW). MHCII and IL-6 
expression was increased after 24 hours in IFNγ+LPS-treated RAW 264.7 cells. IL-10 showed a 
milder increase in IL-4-treated RAWs (not significant) (Figure 3.8 F) at 6 hours of LPS treatment, 
suggesting that these activators did not promote the IL-10 response in RAWs.
3.5. Macrophage paracrine signalling failed to effectively induce EndMT
Cardiac fibrotic processes are initiated by the activation of inflammatory pathways, which are 
triggered upon most types of cardiac injury (79). This accounts for an increase of cytokines, 
chemokines, adhesion factors and proteases during fibrotic injury, which are secreted by myeloid 
cells that have been recruited to the cardiac injury or resident myeloid and stromal progenitors 
which are activated at the local site of cardiac injury. Resident cardiac macrophages are localised 
in direct contact with vascular endothelial cells, at perivascular regions, and contribute to maintain 
cardiac homeostasis in the steady-state heart (169). We and others have shown that the 
macrophage number is increased in the pathological heart. This may be due to influx of newly 
formed monocytes from peripheral hematopoiesis and local proliferation of resident cardiac 
macrophages (144), and although they are indispensable for wound healing macrophages also 
contribute to the onset and worsening of pathological conditions in the heart (178,179).
To recapitulate and study intercellular signalling between cardiac macrophages and endothelial 
cells, we generated mouse GM-BMDM and M-BMDM lines and investigated paracrine 
communication of GM-BMDM and M-BMDM towards endothelial cells. For this purpose, BMDM 
cell lines were cultured in basal media to be able to collect GM-BMDM- and M-BMDM derived 
conditioned medium (CM). MCECs were cultured in media previously conditioned by each BMDM 
lineage and were analysed thereafter for EndMT marker genes. It was found that CM derived from 
M-BMDM or GM-BMBM, either LPS-stimulated or non-stimulated, did not succeed to induce 
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EndMT alone (Figure 3.10. B-G). Furthermore, supernatants derived from resident peritoneal 
macrophages also did not promote EndMT when applied to MCECs (Supplementary material, 
Figure 1). Only CM derived from peritoneal macrophages of thioglycolate solution injected mice 
was able to induce expression of Snail, Acta2 and Twist genes in combination with TGF-ß1 
(Supplementary Data, Figure 2). To further evaluate whether TGF-ß1 was present in the BMDMs-
derived CM, supernatant protein content of TGF-ß1 was analysed by ELISA and no detectable 
protein levels of  TGF-ß1could be found (Figure 3.10, H).   
In light of these results, we asked if bidirectional communication between macrophages and 
endothelial cells could induce EndMT phenotype in endothelial cells. To address this question, we 
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Figure 3.10. BMDMs derived CM has little limited effect on MCECs. A) Schematic drawing of 
conditioned media (CM) experimental plan. Murine bone marrow derived monocytes are differentiated into 
GM-BMDM or M-BMDM macrophages with cytokines GM-CSF or M-CSF. After differentiation and LPS 
stimulation, BMDMs are cultured in basal media, which is conditioned by the macrophages and thereafter 
applied to MCECs. B-D) qRT-PCR results of EndMT markers gene expression of MCECs grown in CM 
from GM-BMDMs. E-F) qRT-PCR results of EndMT markers gene expression of MCECs grown in CM from 
M-BMDMs. Results are shown as means + SEM of triplicate determinants and are representative of eight 
independent experiments (n=8). * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, **** P ≤ 0.0001 H) TGFß-1 protein 
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co-cultured the BMDMs and MCECs in a Transwell® system. Using Transwell® inserts with a 0.4 
µm pore, there is allowance for the exchange of soluble factors between endothelial cells and 
macrophages (paracrine communication) without being physically in contact with each other. 
EndMT gene expression marker analysis after 72 hours of Transwell® co-culture incubation 
showed no significant change of co-cultured cells compared with their mono-culture controls 
(Figure 3.11). 
. 
3.6. Macrophage juxtacrine signalling induces EndMT and is enhanced 
upon macrophage TLR stimulation.
3.6.1. Efficient contact co-culture tracking and separation
To address the possibility of a contact-dependent induction of EndMT by macrophages, MCECs 
and BMDMs were co-cultured in the same tissue culture dish, ensuring direct contact between 
cells. To enable the separation of endothelial cells from macrophages after cell-cell contact 
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Figure 3.11. Paracrine exchange between BMDMs and MCECs does not induce EndMT. A) Schematic 
image of paracrine Transwell® system. B) qRT-PCR results of EndMT markers gene expression of MCECs 
co-cultured with GM-BMDMs and M-BMDMs with and without LPS stimulation. Results are shown as 
means + SEM of triplicate determinants and are representative of three independent experiments (n=3). * 




interaction for further analysiss, a fluorescence live tracking system was designed. In this system, 
MCECs were previously stained in culture with a live fluorescent probe, specifically, an orange Cell 
Tracker CMTMR Dye. CMTMR is taken-up by the cell in culture conditions quickly, and it remains 
in the cell for at least 48 hours(155). CMTMR did not show any signs of cytotoxicity. Endothelial 
cells containing the fluorophore did not proliferate at a different doubling rate (Figure 3.12 A) or 
adopt a different morphology while transporting the tracker (Figure 3.12 B) than native MCECs. 
Also, we could clearly observe that the tracker staining pattern inside the endothelial cell did not 
change through cell cycles, and we visualised no signs of transfer of tracker to neighbour 
unstained cells, as we did not see stained macrophages. Since macrophages are easily 
distinguishable to the naked eye due to their small size in comparison with endothelial cells, we 
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Figure 3.12. Live cell CMTMR fluorescent tracker co-culture and separation. A) Proliferation of 
MCECs stained with CMTMR tracker. MCECs were seeded into six-well plates at a density of 20,000 
cells per well, trypsinized, and counted after 24 and 48 hours. Compared with native MCECs, CMTMR 
tracker did not increase or decrease MCEC proliferation. Experiments were replicated three times, and 
data are presented as means. B) Representative bright field image merged with fluorescence 
microscopy image showing co-culture of RAW 264.7cells (unstained, white) and MCECs (stained, red) 
magnification is 100x. (C-E) FACS separation of co-cultured cells. Representative FACS data showing 
negative control of non stained cells (C), positive control of only stained cells (D), and distinguishable 






could observe that macrophages remained unstained by observing at the fluorescent microscope. 
This allowed for an efficient separation by FACS sorting (Figure 3.12. C-E). The efficient cell 
separation using Cell CMTMR Tracker live-staining has been confirmed in other studies (155,180).
3.6.2. MCECs analysis after co-culture with macrophages
3.6.2.1. Co-culture of MCECs with peritoneal resident macrophages
Peritoneal macrophages (PM) were harvested from the peritoneum of healthy wild type mice and 
cultured following standard procedures. The idea behind using PM was to use a primary cell line 
that could resemble steady-state resident macrophages. We found that PM were strongly attracted 
to endothelial cells and after overnight incubation, the majority of the macrophages were attached 
to endothelial cells (Figure 3.13).
After co-culture and FACS sorting, MCECs were analysed for EndMT markers using qRT-PCR, 
which showed a significant 5-fold induction of EndMT transcription factor Snail and a 60-fold 
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Figure 3.13. Co-cultured peritoneal macrophages. Representative bright field microscopy showing 
peritoneal macrophages (bright round small cells) attached to MCECs.
Figure 3.14. Juxtacrine communication between peritoneal macrophages and MCECs induces 
EndMT. qRT-PCR analysis of MCECs after co-culture with peritoneal macrophages (PM). Results are 
shown as means + SEM and are representative of nine independent experiments (n=9). * P ≤ 0.05, *** P ≤ 
0.001, **** P ≤ 0.0001.
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increase of Acta2 mRNA expression. Macrophage-induced EndMT was enhanced in comparison 
with mono-cultured MCECs and also in comparison with TGF-ß1 treated MCECs (Figure 3.14).
3.6.2.2. Co-culture of MCECs with polarised macrophage cell lines
To also examine the effect of co-culture of MCECs with BMDMs, GM-BMDM and M-BMDM cell 
lines were co-cultured with MCECs. BMDMs were either LPS-stimulated or non-stimulated before 
co-culturing. Co-cultured MCECs were compared to MCECs grown in mono-culture. It was found 
that MCECs grown in contact with BMDMs had an overall enhanced mesenchymal phenotype 
compared to mono-cultured MCEC controls (Figure 3.15). LPS-treated cell lines, both GM-BMDMs 
and M-BMDMs, had an stronger effect than non-stimulated BMDMs. Acta2 and Snail mRNA 
expression was robustly up-regulated in LPS-GM-BMDM and LPS-M-GMDM cell lines, being 
slightly higher in GM-BMDMs. Slug was also up-regulated in native GM-BMDM and LPS-GMDM 
macrophages co-cultures. Interestingly, in MCECs co-cultured with LPS-stimulated M-BMDMs we 
observed a strong induction of Twist, an EndMT transcription factor that does not get up-regulated 
in TGF-ß1-treated MCECs. Overall, this data suggests that TLR-activation in macrophages via 
LPS-stimulation enables them to induce EndMT, and that M-BMDM and GM-BMDM do not seem to 
act distinctly regarding EndMT induction.
Next, we investigated the effect of co-cultures using RAW 264.7 on MCECs. Native, IL-4-, and 
LPS-stimulated IFNγ-RAW 264.7 cells were utilised for co-culture and found that LPS-stimulated 
IFN-γ RAW 264.7 cells consistently induced EndMT (as shown in Figure 3.16) by significantly up-
 59
Figure 3.15. Juxtacrine communication between LPS stimulated BMDMs and MCECs induce EndMT. 
qRT-PCR analysis of MCECs after co-culture with BMDM cell lines. Results are shown as means + SEM of 
triplicate determinants and are representative of three independent experiments (n=3). * P ≤ 0.05, ** P ≤ 
0.01,*** P ≤ 0.001, **** P ≤ 0.0001.
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regulating Slug, Snail, and Acta2 mRNA expression. Col1a1 mRNA expression was enhanced 
almost significantly (P = 0.056008) in LPS-stimulated IFNγ-RAWs, whereas no changes in Twist 
(data not shown) were observed.
To rule out the possibility that LPS itself was the inducer of EndMT despite extensive washing of 
macrophages after LPS-stimulation and before co-cultures with MCECs, we treated MCECs mono-
cultures with macrophage inflammatory inducers IFNγ and LPS, and analysed the cells for EndMT 
markers gene expression after 48h incubation. We found no statistically significant differences in 
EndMT markers mRNA expression in MCECs treated with IFNγ, LPS, or a combination of both. In 
contrast, we found that combination of IFNγ- and LPS-stimulation significantly reduced Snail and 
Col1a1 mRNA expression (Figure 3.17).
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Figure 3.16. Juxtacrine communication between LPS stimulated IFNγ-RAW 264.7 and MCECs 
induce EndMT. qRTq-PCR analysis of MCECs after co-culture with RAW 264.7 cell lines. Results are 
shown as means + SEM of triplicate determinants and are representative of three independent 
experiments (n=3). * P ≤ 0.05, *** P ≤ 0.001.
Figure 3.17. Exogenous LPS does not induce EndMT in MCECs. qRT-PCR analysis of MCECs after 
treatment with IFNγ, LPS, and IFNγ and LPS combined. Results are shown as means + SEM of triplicate 
determinants and are representative of three independent experiments (n=3). ** P ≤ 0.01, **** P ≤ 0.0001.
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In light of these results, we hypothesised that even though cell-cell contact seemed a necessary 
stimulus for macrophages to induce EndMT, cell-cell contact might not be the underlying 
mechanism that directly induces EndMT, but cell contact could rather be an initial step necessary 
for the effector cell (macrophage or endothelial cell) to release soluble signals which in turn induce 
EndMT. To investigate whether cell-contact between macrophages and endothelial cells could be a 
process that results in extracellular production of EndMT-inducing factors, we collected the medium 
conditioned by co-cultures of BMDMs and MCECs (co-culture-CM), and applied them to MCECs. 
We found that endothelial cells treated with TGF-ß1 underwent EndMT, and conditioned medium 
from TGF-ß1-treated cells also induced EndMT (probably reflecting the autocrine feedback 
mechanism effect of TGF-ß reported in endothelial cells and fibroblasts, or due to an unexpected 
long half time of exogenous recombinant TGF-ß). However, we found no effect on MCECs treated 
with CM derived from co-cultures of BMDMs and MCECs(Figure 3.18), suggesting that the cell-cell 
contact itself is necessary for EndMT to occur.
3.6.2.3. Co-culture of MCECs with non-macrophage cells
Next, we wanted to investigate whether the observed effect of macrophage induced-EndMT was a 
macrophage-specific effect or instead, an effect triggered by unspecific cell-contact, regardless of 
the cell source. We wanted to rule out that interaction with a high number of cells could induce 
stress in MCECs which could induce EndMT. In macrophage-MCEC co-cultures, the system was 
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Figure 3.18. Conditioned medium derived from co-cultures does not induce EndMT. RTq-PCR 
analysis of MCEC treated with conditioned medium (CM) derived from native MCEC, from TGF-ß 1 treated 
MCEC, and from co-cultures of MCECs and BMDMs cell lines. Results are shown as means + SEM of 
triplicate determinants and are representative of three independent experiments (n=3). *** P ≤ 0.001
Results
designed so that an average of five to six macrophages were in contact with a single MCEC. To 
explore the possibility that unspecific cell contact interaction could induce EndMT, we chose three 
non-related cell types and performed co-cultures with MCECs following the same protocol used for 
the macrophage cell lines. We used HeLa cancer cells, MCT tubular epithelial cells, and C2C12 
skeletal muscle cells. We examined different cellular ratios (5:1 and 25:1 of MCT and C2C12 to 
MCEC, and 1:1, 5:1, 10:1, 25:1 of HeLa cells to MCEC). 
The results showed no significant up-regulation of EndMT marker genes upon co-culture of 
MCECs with cancer and tubular epithelial cells (Figure 19, A-F). However, we found interesting 
results regarding co-culture with the C2C12 cell line. C2C12 cells are undifferentiated murine 
skeletal muscle cells, e.g. striated muscle myoblasts which share similarity to the striated cardiac 
muscle cells. In fact, studies showed that cardiac-specific proteins like Troponin T can be 
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Figure 3.19. Juxtacrine communication between non macrophage cell lines and MCECs. qRT-PCR 
analysis of MCECs after co-culture with MCT, HeLa, and C2C12 cell lines. Results are shown as means + 
SEM of triplicate determinants and are representative of three independent experiments (n=3). * P ≤ 0.05, 





expressed in C2C12 cells and can be incorporated into their myofibrils (181). C2C12 myoblasts are 
flat, fusiform or star-shaped mononucleated cells. They express sarcomeric and filamentous actin, 
mainly localised at the cell periphery and focal contacts; and they also appear positive for skeletal 
myosin(182). Myoblasts progressively fuse to form multi-nucleate syncytia, the myotubes, which 
further differentiate to acquire the final morpho-functional features of the muscle cells (myocytes)
(181,183). There are several C2C12 differentiation protocols available: addition of 2% horse serum 
to the culture medium, starvation protocols, or addition of insulin supplements (151). Besides, 
subculturing C2C12s to a confluence higher than 70% is also reported to initiate spontaneous 
differentiation(151). In our study, we used two distinct protocols to culture C2C12: one low-
confluence subculture protocol, and a second protocol in which C2C12s were grown until 90-100% 
confluence, to induce spontaneous differentiation. Thereafter, C2C12s were prepared for co-
cultures with MCECs. Co-cultures with undifferentiated, low C2C12:MCEC ratio reported no 
influence on EndMT marker genes in MCECs (Figure 3.19, G-I, “C2C12 ND low”). In contrast, we 
observed a significant up-regulation of Snail and Twist mRNA expression in differentiated C2C12 
with a low C2C12:MCEC ratio (Figure 3.19, G-I “C2C12 D low”). This data suggests that under 
certain conditions cardiomyocytes or muscle cells may be involved in inducing EndMT.
3.6.2.2. Co-culture of native RAW 264.7 and mouse cardiac fibroblasts
Macrophages are known to have pleiotropic functions in the healing heart. They are known to 
induce distinct effects in other cells such as angiogenesis in endothelial cells and myofibroblast 
activation in fibroblasts. Based on reports that evince macrophage link to fibroblast activation, we 
used our established co-culture system with mouse cardiac fibroblasts (MCF) and native RAW 
264.7 cells. Results showed that co-cultures of MCFs with RAW264.7 cells promote myofibroblast 
activation by inducing Collagen I and αSMA mRNA expression in MCFs (Figure 3.20, A-B). 
Furthermore, co-cultures between MCFs and native RAW 276.7 cells dramatically changed 
fibroblast morphology to a stellate morphology with numerous cell extensions (Figure 3.20, C).
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3.7. LPS-stimulated IFNγ-RAW 264.7 cells induce Notch signalling in 
MCECs.
Next, we investigated the underlying mechanism behind juxtacrine macrophage-induced EndMT 
further. Literature on juxtacrine signalling reveals Notch pathway as the paradigmatic intercellular 
signalling mechanism between neighbouring cells. The Notch pathway is activated upon 
interactions between a ligand on the cellular surface of a signal-sending cell, whereas the receptor 
is located on the membrane’s cell surface of an adjacent signal-receiving cell (94-96). Additionally, 
Notch signalling is an unequivocal regulator of developmental cardiac EndMT and has also been 
implicated in adult fibrotic EndMT (93,100,101). Based on these facts, we hypothesised that the 
Notch signalling pathway could be involved in the juxtacrine interplay between macrophages and 
MCECs in our co-culture system. First, whole protein lysates from co-cultured RAWs-MCECs were 
analysed and revealed a strong induction of total Notch1 and its activated form, Notch intracellular 
domain (NICD), only in samples derived from LPS stimulated IFNγ-RAW-MCECs co-
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Figure 3.20. Co-cultures between RAW 264.7 macrophages and Mouse Cardiac Fibroblasts. A)qRT-
PCR analysis of Acta2 expression in MCFs after co-culture with native RAW 264.7 macrophages. Results 
are shown as means + SEM of triplicate determinants and are representative of three independent 
experiments (n=3). ** P ≤ 0.01. B) qRT-PCR analysis of Col1a1 expression in MCFs after co-culture with 
native RAW 264.7. Results are shown as means + SEM of triplicate determinants and represent three 
independent experiments (n=3).*** P ≤ 0.001, **** P ≤ 0.0001 C) Representative immunofluorescence 
pictures showing MCF expressing αSMA (red) in mono-culture (left) and co-culture conditions(right). 









cultures(Figure 3. 21, A). This is consistent with earlier results indicating that this phenotype is the 
strongest inducer of EndMT. We also found that MCECs expressed NICD only in co-cultured 
conditions (Figure 3.21, B). We did not observe a significant change in the mRNA expression of 
any Notch receptor (Notch1, Notch2 and Notch4) in MCECs (Figure 3.21, C-E). The Notch 
pathway activation relies on protease ectodomain cleavage (shedding) of Notch1 by disintegrin 
and metalloproteinase (ADAM) proteases, a process that is initiated upon ligand binding(96). Such 
cleavage releases the activated NICD form, which does not involve an increase in total Notch1 
expression but the nuclear transport of NICD to the nucleus, where it activates target genes. 
Therefore this may explain why RNA levels of endothelial Notch are unchanged in MCECs while 
localisation of NICD is changed. Notch target genes Hes1 and Hey1 were found induced in 




Figure 3.21. LPS-stimulated IFNγ-RAW 264.7 cells induce Notch signalling in MCECs. A) Western Blot 
showing protein expression of protein lysates harvested from co-cultures of IL4-, IFNγ- and IFNγ+LPS- 
RAW 264.7 cells and MCECs, showing polarisation marker iNOS and Notch signalling proteins Notch-1 and 
NICD. B) Fluorescence microscopy picture showing expression of NICD and MHCII markers in mono-
culture of MCECs and co-culture of MCECs with IFNγ/LPS stimulated RAWs. C-E) qRT-PCR analysis of 
expression of Notch-1, -2 and -4  on MCECs (monoculture) and MCEC (RAW co-cultures). The results 
represent the mean + SEM values from two independent experiments. n=2. F-H) qRT-PCR analysis of 
expression of Hey1 Hes1 and Hes5 on MCECs (monocultured) and MCEC with IL4 and IFN+LPS-RAW 
cells (co-cultured). The results represent the mean + SEM values from three independent experiments. n=3. 
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indicating activation of Notch pathway. However, the expression of Hes5 , another Notch signalling 
pathway target gene, was not induced. 
We next investigated whether the increase of total Notch observed in total lysates could be due to 
induction in RAW 264.7 cells. Analysis of RAW264.7 cells revealed an increase of Notch1, and no 
increase in Notch2 and Notch4 mRNA expression, in RAW264.7 cells that were stimulated with 
IFNγ and LPS(Figure 3.22 A). In addition, we found that LPS-stimulated IFNγ-RAW expressed the 
mammal Notch ligand Jagged1, after 6 hours of LPS-stimulation (Figure 3.22 B).
Taken together this data suggest that Notch1 is shed and therefore is activated in MCECs upon 
contact with LPS-stimulated RAW 264.7 macrophages, resulting in upregulation of Notch targets 
genes Hey1 and Hes1. This induction may be triggered by induced expression of Jagged 1 in LPS 
stimulated IFNγ-RAW cells, therefore functioning as the Notch signal-sending cells.
3.8. Wnt canonical signalling is affected in LPS-co-cultures. 
Wnt signalling modulates intercellular communication between neighbouring cells, playing an 
important role in cell fate decisions. Similar to other intercellular signalling pathways, the Wnt 
ligand is synthesised and secreted from one cell and binds to a co-receptor complex on a 
neighbouring cell. β-Catenin is the central protein in the canonical activation of the Wnt pathway. 
When ß-catenin is located at the cell membrane, it interacts with E-cadherin and α-catenin, 
stabilising the intracellular part of adherent junctions and serving as a coupling connection to the 
cytoskeleton. When Wnt is absent, β-catenin is phosphorylated on the serine–threonine residue of 
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Figure 3.22. Notch is activated upon TLR simulation in IFNγ-RAW 264.7 macrophages. A) qRT-PCR 
analysis of expression of Notch-1, -2 and -4 on RAW264.7 mono-cultures upon cytokine IL4 and IFN/LPS 
overnight stimulation. The results represent the mean + SEM values from three independent experiments. 
n=3.** P ≤ 0.01. B) Representative immunoblots of IFN-RAW mono-cultures Notch expression upon time-
course stimulation with LPS showing expression of Jagged1 and NICD. Loading control is shown with Actin 
expression.
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forming a complex with APC and Axin. This complex is recognised by ß-transducing repeat 
containing protein and the E3 ubiquitin ligase, which induce proteasome degradation of β-catenin. 
When the Wnt pathway is activated upon Wnt ligand binding to Frizzled co-receptors, Wnt 
promotes a conformational change in Frizzled that results in the exposure of a binding cytoplasmic 
domain that competes for Axin. Degradation machinery led by Axin becomes obsolete and allows 
ß-catenin to accumulate in the nucleus, where it promotes transcription of target genes (104).
The canonical Wnt pathway has been implicated in EMT in cancer and kidney fibrosis, and 
furthermore in adult and developmental EndMT. Wnt is an antagonist for VEGF during cardiac 
valve formation and is increased in endothelial cells undergoing EndMT. After myocardial infarction, 
canonical Wnt-positive cells accumulate in the infarcted area, and evidence from lineage tracking 
studies has revealed that mesenchymal Wnt-positive cells in this region are derived from 
endothelial cells(107,108).
We were therefore interested in the role of canonical Wnt signalling during macrophage induced-
EndMT. Interestingly, we found that localisation of ß-catenin changed from the membrane to the 
nucleus upon co-culture of MCECs with native RAW264.7 macrophages,(Figure 3.23, A), what 
corresponded to an increase in mRNA expression of the transcription factor Wisp2 (Wnt1-inducible 
signalling pathway protein 2) (Figure 3.23, B).
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Figure 3.23. ß- catenin exhibits nuclear localisation in MCECs under co-culture conditions with LPS 
stimulated IFNγ-RAW 264.7 macrophages. A) Representative immunostaining pictures of ß-catenin 
expression in MCECs. Left panel, mono-cultured MCECs express ß-catenin (red) at the membrane 
regions. Right panel, MCECs co-cultured with LPS stimulated IFN-RAW macrophages expressing F4/80 
(green) showing ß-catenin (red) transported to the nuclei (blue). B) Wisp2, a downstream target of ß-
Catenin pathway, is induced in LPS stimulated IFNγ-RAW cells. qRT-PCR data from a three technical 
replicates from one experiment (n=1). 
mono-culture co-culture  
DAPI/ ß-catenin/ F480 DAPI/ ß-catenin/ F480
BA
Results
3.9. MCECs and MCECs undergoing EndMT change RAW 264.7 
phenotype.
Macrophages are highly sensitive cells that are continuously surveying their surroundings in search 
for pathogens or damage signals, sensing changes in homeostasis (135). In the heart, 
macrophages have been detected to be in direct contact with cardiomyocytes and endothelial 
cells(169). It is safe to assume that when a macrophages’s neighbouring cells change their 
morphology, the macrophage will detect that stimulus and respond to it, in order to achieve 
homeostasis. For example, protective alternative phenotype CX3CR1high, Ly-6Clow patrolling 
monocytes are reported to be increased in the dysfunctional endothelium of atherosclerotic 
plaques, where they attempt to protect the endothelial layer (184). We hypothesised that 
macrophages that were in direct contact with MCECs could also respond differently when 
encountering endothelial cells undergoing EndMT, in comparison to encountering native 
endothelial cells. Therefore, we questioned whether macrophage inflammatory patterns changed 
under co-culture with MCECs or MCECs undergoing EndMT. To investigate this, we performed co-
cultures between polarised RAW.264.7 cells and MCECs that had been cultured before in either 
normal growth conditions or in TGFß-1-treated conditions, and thereafter macrophage phenotype 
was analysed. We examined pro-inflammatory markers TNF-α, CCL2, and MHCII in native, IL-4- 
and IFNγ/LPS-treated RAW 264.7 cells. Results showed a significant impact on endothelial cells in 
macrophages. This was reflected by a robust induction of CCL2 expression in all RAW cell lines 
tested upon contact co-culture with native endothelial cells (Figure 3.24). Interestingly, this 
induction was significantly reduced when macrophages were co-cultured with EndMT-MCECs. 
Nevertheless, macrophage CCL2 expression was still enhanced in all co-cultures in comparison 
with mono-cultured macrophages. TNF-α expression did not change upon co-culture conditions in 
native and IL-4- RAWs. By contrast, TNF-α of pro-inflammatory IFN-LPS RAW macrophages was 
repressed upon co-culture with MCECs undergoing EndMT. Co-culture did not have a strong effect 
on MHCII mRNA expression in native and IL-4-RAWs, with a mild but significant decrease in native 
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RAWs-native MCECs co-cultures. Instead, in pro-inflammatory IFNγ/LPS stimulated RAWs, MHCII 
expression was strongly repressed, in co-cultures with either native or EndMT-MCECs. This data 
suggests that pro-inflammatory macrophages are taken back to a less inflammatory, resting-like 
state upon contact with endothelial cells, an effect that is enhanced upon co-culture with EndMT-
MCECs.
Next, we investigated whether the effects of endothelial cells on pro-inflammatory macrophages in 
co-cultures could be recapitulated in a paracrine system. Therefore, we collected conditioned 
medium from endothelial cells cultured in normal conditions or according to the EndMT protocol. 
We put special attention that TGF-ß1-treated cells were extensively washed and passaged to a 
new dish to avoid contamination of exogenous recombinant TGF-ß1. After culturing IFN/LPS-RAW 
in Native-CM or EndMT-CM, we analysed mRNA expression of pro-inflammatory markers and 
found consistently that TNF-α and MHCII were significantly repressed upon treatment with EndMT-
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Figure 3.24. Polarisation marker mRNA expression of RAW 264.7 macrophages under MCEC 
juxtacrine co-culture conditions. Differential cytokine mRNA expression and activation pattern of RAW 
264.7 when mono-cultured, co-cultured with native MCECs and co-cultured with EndMT-MCECs as 
measured by qRT-PCR. Levels TNF-α, CCL2 and MHCII were normalised to an endogenous reference 
(B2M) and calibrated to mono-culture conditions for each marker. The results represent the mean + SEM of 
values from two independent experiments. * P ≤ 0.05, ** P ≤ 0.01, **** P ≤ 0.0001 in co-cultures vs mono-











CM in comparison with native CM and basal DMEM culture control (Figure 3.25). Paradoxically, we 
found that Ccl2 mRNA expression was downregulated under treatment with Native-CM in 
comparison with control DMEM and to EndMT-CM, which appeared to have no effect on CCL2.
We further wanted to explore whether downregulation of pro-inflammatory markers observed in CM 
experiments corresponded with an upregulation of pro-fibrotic macrophage phenotype associated 
markers. We analysed markers associated with macrophages and monocytes in pro-fibrotic 
environments, as we hypothesised that MCECs undergoing EndMT are detrimental pro-fibrotic 
signal-sending cells. Endothelial cells under pro-fibrotic stimuli (such as TGF-ß1), contribute to the 
release of TGF-ß1 by an autocrine feedback mechanism. In addition, we hypothesised that cells 
undergoing EndMT may behave as a fibroblast-like cell and therefore contribute to the fibrotic 
microenvironment. Analysis of chemokines Ccl17 and Ccl22, alternative-activated transcription 
factor promoter Stat3, and pro-fibrotic factors TGFß-1, TGFß-2 and CTGF revealed a significant 
downregulation upon treatment with CM derived from native MCECs. This negative effect was 
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Figure 3.25. Endothelial derived CM changes RAW 264.7 phenotype. Differential cytokine mRNA 
expression and activation pattern of RAW 264.7 upon treatment with MCEC derived CM, as measured by 
RTq-PCR. Levels of TNF-α, Ccl2 and MHCII (pro-inflammatory), Ccl17, Ccl22, Stat3, Tgfß1, Tgfß2 and 
CTGF (pro-fibrotic9), were measured and normalised to an endogenous reference (HPRT) and calibrated 
to control cells. The results represent the mean SEM of values from two independent experiments. * P ≤ 
0.05 and **** P ≤ 0.0001 represent statically significance between Native and EndMT derived CM. ! P ≤ 
0.0001, represent statically significance between DMEM control and EndMT derived CM treated cells. ns= 
no significant. 
Results





EndMT is a process that is active in embryonic cardiac development and under stress pathogenic 
conditions in adulthood. Biochemical inducers of EndMT have been described by many, pointing at 
damage-inducing signals such as TGF-ß 1 and 2, hypoxia, and others. Still, specific cellular 
effectors that induce EndMT in the context of disease remain elusive. Macrophages are immune 
cells present at pathogenic sites modulating the interstitial environment and are known to 
contribute to homeostasis and disease.
The aim of this project was to investigate the crosstalk between macrophages and EndMT in the 
context of cardiac fibrotic disease. To this end, macrophages were detected in human and mouse 
models of cardiac fibrosis from diverse disease backgrounds and found to be significantly 
increased with respect to healthy controls, correlating with fibrosis. To evaluate the effect of 
macrophages alone on endothelial cells, cell culture tools were established to distinguish paracrine 
from juxtacrine intercellular signalling. An efficient live cell tracking separation method for co-
culture of endothelial cells and macrophages under cell contact conditions was established, and 
served to find that macrophages robustly induced EndMT solely under juxtacrine but not under 
paracrine conditions. Interestingly, pro-inflammatory, TLR stimulated macrophage phenotype 
induced EndMT even more than generated anti-inflammatory and steady-state macrophages. We 
further observed that Wnt and Notch intercellular signalling pathways were activated in endothelial 
cells under co-culture conditions. Finally, we found that a negative feed back loop exists in that 
sense that macrophage inflammatory properties were impaired under contact with endothelial cells 
undergoing EndMT.
4.1. Cellular interplay in Cardiac Fibrosis
4.1.1.Myocardial Infarction
In humans, MI occurs as a consequence of a thrombotic occlusion, which occurs as a complication 
of atherosclerotic plaque rupture in patients with other underlying diseases. Metabolic conditions 
such as diabetes and obesity accelerate the atherosclerotic process. Immediately after myocardial 
acute ischemic failure, a sequential cascade of cellular events takes place to repair the damage: In 
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short, an effective healing process after myocardial infarction is initiated by i) an inflammatory 
phase, with the purpose to clear the wound from dead cells, seconded by ii) a proliferative phase 
with an inhibition of the inflammatory response and induction of ECM secreting myofibroblasts and 
new vasculature formation, and finalised by iii) an inhibitory phase, where fibroblasts and nude 
vessels leave a life-saving scar (4, 79, 114).
Such a timely regulated process requires a complex intercellular coordination that involves several 
events. Firstly, cardiomyocytes near blood-depleted vasculature become ischemic, and die rapidly 
by necrosis. Necrotic myocytes release their intracellular content to the extracellular space, a 
process that initiates an inflammatory response when cell membrane receptors detect intracellular 
ligands and fragmented matrix as “danger signals” (DAMPs), which activate the innate immune 
system. Thereafter, complement cascade, TLR-mediated pathways and ROS activate the 
expression of adhesion molecules in endothelial cells and the production of pro-inflammatory 
cytokines and chemokines in fibroblasts, leukocytes and vascular cells through NF-"B related 
pathways.
By this point, pro-inflammatory cytokines TNF-α, IL-1ß and IL-6 are released. IL-1ß is known to 
stimulate leukocyte recruitment and mediates synthesis of chemotactic mediators. TNF-α 
stimulates expression of pro-inflammatory cytokines, chemokines and adhesion molecules in 
leukocytes and endothelial cells and regulates extracellular matrix metabolism in fibroblasts, while 
its actions on cardiomyocytes are apoptotic and contraction inhibiting. Pleiotropic effects of TNF-α 
may be due to binding to TNFR1 and TNFR2 receptors with differential biologic consequences.
Release of such damage signals stimulate the infiltration of circulating cells. In mice, the first 
population to infiltrate the infarcted myocardium are leukocytes, in charge of debris removal by 
phagocytosis. Monocytes recruitment appears next and rapidly outnumber leucocytes. There is 
evidence of a phenotypical shift in monocyte populations detected in the infarcted heart as 
inflammation resolves. Immediately after MI, a population of Ly-6Chigh monocytes invades the 
myocardium. Ly-6Chigh monocytes are known to exhibit pro-inflammatory features, producing high 
levels of pro-inflammatory cytokines and proteases. A less inflammatory milieu follows, Ly-6Clow 
monocytes, which are known to express VEGF and TGF-ß, partially substitute the initial pro-
inflammatory monocyte population (Figure 4.1). Accordingly, human clinical data describe a similar 
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scenario with high accumulat ion of pro-
inflammatory CD16− CD14+ monocytes post MI and 
the emergence of  less inflammatory CD16high 
CD14low after. Once at the organ tissue, monocytes 
differentiate to macrophages, acquiring tissue-
specific characteristics (169). Macrophages are 
thought to orchestrate resolution of inflammation 
and modulate transition to a reparatory phase by 
mechanisms like production of extracellular TGF-ß 
1, a cytokine that because of its pleiotropic identity 
induces apoptosis of leukocytes and stimulates 
proliferation of fibroblasts and myofibroblast activation. When apoptotic, neutrophils are engulfed 
by macrophages, a process that releases TGF-ß, which is therefore essential for inflammation 
resolution. This is in contrast to necrotic digestion, which occurs during earlier phases and 
conversely enhances inflammation. 
Evidence regarding the time frame when EndMT is triggered during MI resolution demonstrates 
that mesenchymal cells with endothelial origin are detectable at day 7 after LAD coronary artery 
occlusion. Induction of Wnt signalling and chronic inflammation exhibited in patients with 
thrombosis which together with the hypoxic environment at the site of the infarct indicates a 
precondition known to induce EndMT (57). This therefore may lead to early induction of EndMT. 
Our data regarding the EndMT-inducing effect of TNF-α and IL-1ß in MCECs suggests that during 
the inflammatory phase after MI a number of endothelial cells undergo EndMT induced by the 
direct effect of TNF-α and IL-1ß signals. In addition, TGF-ß 1 signalling is initiated at the interphase 
between inflammatory and proliferative phases. It therefore seems plausible that TGF-ß 1, under 
such scenario, also triggers EndMT. 
In the last years a few studies have been able to shed some light on cardiac macrophage ontogeny 
providing evidence that distinct lineages that accumulate in the healthy heart have both embryonic 
and hematopoietic origin. Under stress, sources of macrophages are also very likely to arise from 
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Figure 4.1. Potential lineage relationships of 
monocytes and macrophages after myocardial 
infarction. Adapted from Nahrendorf and Swirski 
et al 2013. 
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resident proliferation, bone marrow and even liver derived progenitors (186). Importantly, these 
populations have been shown to have differential functionality (126). Considering this, in this study, 
we sought to gain insight in the macrophage phenotype able to induce EndMT. We found that 
EndMT was better induced, although not exclusively, by macrophages with a pro-inflammatory 
phenotype and stimulated with TLR-agonist, E.Coli derived LPS. Although Toll like receptors are 
specialised in their recognition of special patterns typically associated with pathogens, they also 
recognise endogenous signals derived from damaged tissues, such as heat shock proteins or 
fibronectin fragments. For example, LPS induces signalling by activating TLR-4 through TLR-2 
receptor (186). TLR4 is expressed in the heart and is induced in murine infarcted myocardium and 
in samples obtained from cardiomyopathic hearts (187). Interestingly, while TLR4 knock out mice 
have decreased infarct size, suppressed inflammation, (188) and attenuated adverse remodelling 
post infarction (189), TLR2 deficient mice exhibit similar infarct size and inflammatory leukocyte 
infiltration compared to wild type controls, but display decreased fibrosis in the non-infarcted area 
and attenuated post- infarction ventricular remodelling (190). Taken together, this data suggest that 
in the context of post MI healing process, TLR activated macrophages recruited or resident at the 
infarct could, via TLR2 or TLR4 activation, induce EndMT. 
Even though the physiological role, beneficial or detrimental, of EndMT after MI is not yet clear, 
findings in related pathomechanisms are insightful to speculate on its putative role. EndMT has 
been associated with vasculogenesis in embryonic development (54). EndMT signalling after MI 
could serve as a source of mural cells to offer support for newly formed vessels to progress to 
promote healing. Furthermore, EndMT could contribute, as a source of ECM producing 
mesenchymal cells, to help scar formation. Nevertheless, fibroblasts derived from EndMT have not 
been yet fully characterised. The insightful study by Evrard and Lecce (72) revealed that EndMT 
derived fibroblast-like cells behave as deleterious “incompetent” fibroblasts, exhibiting impaired 
MMP metabolism with respect to control fibroblasts. Thus, similarly to atherosclerotic plaque in 
which EndMT contributes to instability, EndMT may contribute not to facilitating scar formation, but 
contrarily to destabilisation of its formation.
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4.1.2. Progressive and chronic cardiac fibrotic conditions
While inflammatory and fibrotic responses after MI are well established, evidence demonstrated 
that inflammation and fibrogenic pathways are also triggered in chronic cardiac disease (114). 
Sublethal insults such as pressure overload, volume overload and short recurrent ischemic events 
that result in microscopic or no cardiomyocyte loss, lead to transient, low-key levels of 
inflammation. Pathophysiological mechanisms of chronic cardiovascular diseases leading to 
interstitial and perivascular fibrosis are heterogeneous and caused by several factors such as age, 
metabolic and genetic conditions (11-13). In these cases, the cellular effectors involved in 
progression of fibrosis (direct mediators such as fibroblasts, or indirect mediators such as: 
macrophages, mast cells, lymphocytes, cardiomyocytes and vascular cells) are similar however it 
is it is their relative contribution that dictates the underlying cause of fibrosis.
4.1.1.1. Aortic Stenosis
In patients with aortic stenosis (AS), the adaptation to normalise systolic wall stress triggered by 
high intracavitary pressure results in left ventricular hypertrophy, cardiac disfunction and 
myocardial fibrosis (165). In fact, higher values of myocardial fibrosis in these patients have been 
associated with worse prognoses (165). Our data shows accumulation of macrophages in the 
myocardium of patients with AS and a positive correlation with the amount of cardiac fibrosis. 
Furthermore, this is also reflected in the murine aortic stenosis model of ascending aorta 
constriction (AAC) and also in Angiotensin II (Ang II). Recruitment of macrophages in AS in 
humans and in murine models of Ang II and aortic banding indicates a role of the immune system 
even in absence of acute inflammatory response. These findings, suggesting that macrophages 
induce EndMT through a close contact mechanism, are in line with the fact that in myocardial 
fibrosis progression there is no acute inflammation. Since mild transient inflammatory induction 
may occur in chronic disease (114), macrophages which, according to our data, present in 
substantial numbers in the steady-state myocardium, and which are reported to be located in close 
contact with vascular cells (169), may be able to induce EndMT by juxtacrine contact mechanism. 
Thus, acute inflammation may to be needed in vivo for macrophages to induce EndMT. Our data 
shows that even steady-state macrophages, when in contact with endothelial cells are capable of 
inducing EndMT. Peritoneal macrophages exhibited a strong capacity to induce EndMT under 
contact conditions (Figure 3.14) while their EndMT induction through CM was limited. This data 
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suggests that in situations where inflammation is reduced, the impact of macrophages in tissue can 
still promote mesenchymal fibrotic phenotype in endothelial cells. 
At the aortic valve, accumulation of macrophages is associated with valve calcification, a common 
feature of valve stenosis clinical complication (165). In the valve, valve interstitial cells (VICs) 
differentiate to myofibroblast-like cells and to osteoblast-like cells, a process linked with age, 
atherosclerosis and inflammation. Osteoblast accumulation has been directly associated with 
EndMT, as valve aortic endothelial cells (VECs) have been demonstrated to delaminate and 
express pluripotent and osteogenic-like markers (165,191). Moreover, LPS stimulated 
macrophages have been shown to induce calcification in VICs (192). Taken together this suggests 
that while located within the myocardium and in perivascular regions macrophages may be 
involved in promoting fibrosis through EndMT. In addition, , macrophages at the valve may be 
involved in stimulating EndMT in VECs, contributing to thickening and stiffening of the valves via a 
valve osteogenic EndMT process. 
4.1.1.2. Diabetic Cardiomyopathy
Diabetes is an independent risk factor for cardiovascular diseases and it contributes to 
cardiomyopathy and fibrosis (206). Reports show that inflammation is induced in rodent models of 
diabetes, which has also been corroborated in diabetic patients (186). Inflammation has a 
deleterious impact in the cardiac endothelium and plays an important role at the onset and 
progression of diabetes and obesity (13). Pro-inflammatory macrophages promote insulin 
resistance and adipose inflammation. The release of inflammatory cytokines and fatty acids by 
adipocytes induces activation of macrophages and a generalised chronic low grade inflammation in 
tissues. Pro-inflammatory, LPS-stimulated macrophages are known to produce resistin, which 
promotes insulin resistance and adipose inflammation. 
Macrophages have been directly linked to diabetic cardiomyopathy in studies showing that an anti-
inflammatory macrophage conversion via BMP-7 signalling ameliorates adverse cardiac 
remodelling (193). Studies have shown that high glucose levels are able to directly induce the 
expression of inflammatory cytokines TNF and IL-6 in fibroblasts, cardiomyocytes and 
macrophages. Moreover, high glucose levels also have been shown to promote EndMT in human 
aortic endothelial cells (59). Our study demonstrates that macrophages accumulate in the 
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myocardium of patients with diabetes and suggests that macrophages may be associated with a 
pathological role in promoting fibrosis via EndMT in these patients.
4. 1.1. 3 Atherosclerosis
Macrophages and endothelium are key cellular mediators of atherosclerotic process. Accumulation 
of atherogenic low-density lipoprotein (LDL) and remnant proteins, together with the atherogenic 
susceptibility of focal flow-disturbed arterial regions, and usually in parallel to other systemic 
conditions such as age, diabetes and obesity (diabetes is known to accelerate atherosclerosis 
(194), induce activation of endothelium and subsequent endothelial dysfunction and progressive 
recruitment of monocytes within the inflamed region. This study was interested in this model due to 
the known established contribution of macrophage accumulation to the pathological process, and 
found that accumulation of macrophages in ApoE deficient mice is associated with increased 
EndMT and induction of Twist in atherosclerotic lesions (Figure 3.4) as compared to their wild type 
counterparts. In this model, wild type mice also acquire certain atherosclerotic condition after being 
fed with a high fat containing “western” diet, which includes high fat nutrients, promoting 
atherosclerosis. In a recent atherosclerosis study reported by Evrard and Lecce et al, EndMT was 
a recurrent mechanism in atherosclerotic plaques that promotes fibroblast homeostasis disruption 
by accumulation of mesenchymal-like cells with an endothelial origin that exhibit aberrant ECM 
regulation properties. In their study, macrophages direct contribution is not investigated nor 
quantified, although it was indicated that some macrophages were found  in plaques express TGF-
ß. 
4.2. Underlying mechanisms of macrophage-induced EndMT
4.2.1. Paracrine signalling
In this study it was demonstrated that macrophages alone are capable of directly inducing EndMT 
in MCECs. In light of the in vivo data in human and mouse correlating increase of macrophage 
number with fibrosis, in vitro studies allowed us to elucidate whether macrophages have direct 
EndMT inducing capabilities and under which conditions this may occur. An interesting and yet 
surprising finding was that macrophages were unable to induce EndMT in a paracrine manner. 
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Inflammatory cytokines are known to be expressed in the fibrotic myocardium of mice models of 
Ang II and aortic banding models (79,120). In this study we have shown that inflammatory 
cytokines TNF-α and IL-1ß induce EndMT, however experiments with conditioned medium from 
macrophages failed to induce EndMT in a paracrine dependent manner. It is evident that 
macrophage cytokine signalling is a paracrine intercellular signalling. However, contrary to our 
expectations, we did not observe EndMT induction in MCECs treated with macrophage-derived 
CM. The are several possible explanations for this perplexing result. First, EndMT is a process 
highly regulated in endothelial cells, that only occurs under discrete situations when several 
damage-related signals are applied. In both embryonic development and in the context of fibrosis, 
hypoxia and TGF-ß signalling are known to co-stimulate EndMT processes. It is possible that the 
inflammatory concentration of macrophage-derived CM was not a strong enough stimuli to induce 
EndMT alone, and that perhaps stronger and additional signalling is needed to activate EndMT 
program in MCEC cells.
Moreover, cytokine IL-1ß, known to be induced upon TLR stimulation in macrophages and also 
known to induce EndMT, requires several stimuli to induce its activation. IL-1ß is transcribed upon 
TLR stimulation, however, it is transcribed into its precursor form pro-(IL-1ß) (195). In order to be 
catalysed into its biologically active and secreted form, pro-(IL-1ß) needs the further activation of 
the inflammasome, a complex that needs an additional stimulation to be formed (196). 
Interestingly, we observed stimulation of EndMT in experiments where conditioned medium was 
isolated from thioglycollate elicit peritoneal macrophages. However, these experiments could not 
be continued due to animal-handling challenges, as the use of thioglycollate is no longer supported 
by the agency of animal care (LAVES Niedersachsen). Thioglycollate elicit macrophages (thio-
PMs) are newly recruited macrophages to the murine abdominal cavity as a response of a highly 
acute inflammatory reaction caused by the intraperitoneal injection of Thioglycollate medium, a 
highly nutritious bacterial broth solution that promotes bacterial growth. Newly recruited thio-PMs 
are typically highly inflammatory, therefore it is possible that the “primary cell line” nature of thio-
PMs, together with their high pro-inflammatory profile permitted access to harvesting of highly 
inflammatory CM that was able to induce EndMT in combination with TGF-ß 1. However, this 
highly inflammatory conditions do not reflect the purpose of this study. Therefore it is proposed that 
the thioglycollate model may be a model more suitable for pathophysiological infectious or acute 
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cases such as endocarditis or sepsis conditions, rather than mimicking a study of chronic 
inflammation in the context of cardiac fibrosis. 
Nevertheless, in an attempt to rule out the possibility that the soluble cytokines and factors 
contained in CMs could undergo protein degradation rapidly, and therefore be unable to induce 
EndMT when applied to MCECs, Transwell® inserts were utilised. In such experiments, 
macrophages and MCECs shared the same culture medium, allowing for bidirectional signalling 
between the two cell types (Figure 3.11). Direct cell-cell contact, however, is not possible in this 
system. Here, the possibility that proteins were degraded was null, and yet we still saw no effect in 
EndMT gene expression.
Experiments of MCEC-derived CM on macrophages need to be considered for a careful 
interpretation of results. In light of the findings studying macrophage activation behaviour under co-
culture with MCECs, we found macrophage activation markers downregulated upon CM of native 
MCEC cells. It is possible that in Transwell® experiments macrophage activation was being 
hampered by endothelial signalling and thus disabling them from activating EndMT. Since 
macrophages may be inactivated by MCEC-derived CM, it is possible that they were also ongoing 
inactivation under Transwell® co-culture. These findings may seem paradoxical, however, may as 
well be interpreted that as macrophages induce EndMT juxtacrinally, MCECs try to avoid 
undergoing EndMT by blocking the macrophage effect in a paracrine manner in what appears to 
be a negative feedback loop. As previously stated, EndMT is a highly regulated phenomena as 
such for EndMT to occur a highly pro-fibrotic, pro-inflammatory environment, or close contact is 
necessary in order to unbalance endothelial identity. The role of macrophage inactivation by 
endothelial cells is furthered discussed in the proceeding section. 
4.2.2. Juxtacrine signalling
In this study we unequivocally, in this study we demonstrated that macrophages induce EndMT in 
MCECs via a juxtacrine mechanism. This was shown by co-culturing macrophages and live-
fluorescent endothelial cells in cell-cell contact conditions and separating different cell populations 
by FACS sorting (Figure 3. 12). After separation, MCECs were analysed for EndMT and 
mesenchymal markers. Snail, Slug and Acta2 (gene coding for α-SMA) were consistently up-
 80
Discussion
regulated in MCECs co-cultured with LPS-stimulated GM-BMDMs and LPS stimulated IFN-RAW 
264.7 macrophages. PMs recovered from healthy mice also showed strong induction of genes 
Snail and Acta2 under this mechanism. 
 Further investigation in the signalling mechanism under macrophage-endothelial juxtacrine 
communication led to interesting findings in the Notch signalling pathway, a classical and well-
known example of juxtacrine signaling relevant for EndMT. A strong increase of total Notch 1 and 
activated Notch (NICD) at the protein level in whole co-cultures of IFNγ- and LPS-stimulated 
RAW264.7-MCECs, but not in basal or IL4-RAW264.7 cells was identified ( Figure 3.21., A). Notch 
signalling pathway activation in MCECs was detected by immunostaining of NICD and confirmed 
Notch signalling activation in co-cultured MCECs by analysing consequent expression of Notch 
target genes Hes1 and Hey1 (Figure 3.21., B-H). This activation was also specific of LPS-treated 
RAW 264-7 co-cultured MCECs. mRNA transcripts of Notch 1, 2 and 4 were further analysed and it 
was found that while endothelial Notch 1 remain unchanged in endothelial mono-cultures and co-
cultures, in INF-LPS RAW cells Notch 1 was increased (Figure 3.21., C-D and Figure 3.22 A). 
Literature shows that Notch signalling has a specific role in macrophages by driving polarisation 
towards a pro-inflammatory phenotype (197,198). This is probably reflected in the Notch induction 
observed in co-cultures using IFNγ-RAW 264.7 cells stimulated with LPS, consistent with findings 
by other groups using LPS stimulated RAW 264.7 cells (197). This data suggests that even though 
Notch1 is activated in macrophages, Notch activation in endothelial cells, as reflected by NICD 
intracellular staining and up-regulation of Hes1 and Hey1 (100), has a different function than 
macrophage-Notch, and may play a role in inducing EndMT. Notch signalling is known to drive 
EndMT in development and is known to promote EndMT in vitro (93,98). We speculate that 
activated macrophages may function as the signal sending cells via a juxtacrine signalling process 
to induce EndMT in endothelial cells. This may be driven by increased expression of Jagged 1 
ligand at the macrophage membrane (Figure 3.22), increasing Jagged1 binding to endothelial 
Notch and favouring endothelial Notch shedding and activation of endothelial Notch intracellular 
signalling.
In addition, it was found that canonical Wnt signalling was activated in co-cultures of RAW 264.7 
cells and MCECs by visualising ß-catenin located at the nuclei in MCECs upon co-culture (Figure 
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3.23). Further work has to be done to investigate the putative link between ß-catenin internal 
localisation in endothelial cell contact co-culture with macrophages. It has been suggested that 
canonical Wnt activation and ß-catenin internal localisation can be achieved via an independent 
Wnt process, by changes in cadherin organisation at the cell membrane (207). Wnt pathway has 
been shown to be active in neural crest cells undergoing EMT, despite not expressing significant 
amounts of Wnt ligand (208). Moreover, during gastrulation, epiblasts delaminate and migrate to 
form the mesoderm in another form of EMT, in a process dependent of Wnt/ß-catenin pathway but 
independent of Wnt ligand expression (209,210). The role of ß-catenin nuclear localisation 
independent of Wnt ligand is thus an interesting hypothesis to follow up in the investigation of 
macrophage-induced canonical Wnt.
Furthermore, there is evidence of cooperative and antagonistic crosstalk between Notch and Wnt 
signalling (211,212), highlighting the importance of cellular context to drive cell fate decisions. 
4.3. Macrophage polarisation in the context of EndMT
Macrophages are cells highly dynamic and vulnerable to microenvironment changes in their 
surroundings. Failure of macrophages to be properly activated in response to their environment 
contributes to a broad spectrum of pathologies (213-215). We sought to gain insight in 
macrophage biology in the context of EndMT by analysing macrophage phenotype after a period of 
exposure to endothelial and EndMT signals. The markers chosen to address macrophage 
activation status were representative of a spectrum of polarisation: TNF-α, MHCII and CCL2 are 
known pro-inflammatory markers, while chemokines Ccl17 and Ccl22 are known markers for 
wound-healing macrophages (216), transcription factor Stat3, is a known marker for alternative 
activated macrophages involved in phagocytosis and repair, and its activation is required for 
effective inhibition of TNF-α (217). Tgfb1, Tgfb2 and Ctgf are genes associated with pro-fibrotic 
macrophages (217). Strikingly it was found that macrophage expression of pro-inflammatory 
markers, as well as pro-fibrotic markers, was reduced upon treatment with CM derived from native 
MCECs. This inhibition was significantly intensified, in macrophages treated with CM derived from 
EndMT-MCECs, especially with respect to the expression of TNF-α, MHCII , Ccl17, Ccl22, Stat3, 
Tgfß1 and Ctgf markers.
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Endothelial cells are known to display differential effects on monocytes and macrophages 
depending on their status: Upon injury, activated endothelium is known to undergo activation and 
up-regulate selectins, CCL chemokines, complement and inflammatory mediators (218). Moreover, 
necrotic endothelial cells have been reported to promote recruitment of Ly6Clow anti-inflammatory 
monocytes, which then orchestrate the killing of the necrotic endothelial cell via leukocyte action 
(219). Additionally, necrosis promotes inflammatory microenvironment that further recruits 
inflammatory cells (4). Whether necrotic cells are able to shift macrophages phenotype has not 
been investigated. By contrast, apoptotic endothelial cells are known to have an anti-inflammatory 
effect in macrophages, not only by the release of TGF-ß1 upon phagocytosis, but also through 
modifying the microenvironment by secretion of particles, in a mechanism that shifts macrophages 
to a less inflammatory phenotype (220). Endothelial cells undergoing EndMT are not yet defined as 
neither necrotic nor apoptotic cells. Our data indicates that EndMT cells dramatically reduce 
macrophage activation via a paracrine mechanism, shown by the negative regulation of 
inflammatory and pro-fibrotic gene expression markers (Figure 3.24).
However, the collected data indicates a differential effect in paracrine versus juxtacrine signalling in 
between RAW 264.7 cells and MCECs. In RAW 264.7 cells, the inhibition of pro-inflammatory 
markers observed in CM experiments is associated with a similar inhibition of pro-inflammatory 
markers observed in RAW cells under contact-co-culture experiments, with the exception of CCL2 
chemokine. CCL2 chemokine was found up-regulated in macrophages upon contact co-culture 
with native MCECs and with MCECs undergoing EndMT. CCL2 chemokine is one of the most 
studied CC chemokines and is known foremost because of its monocyte chemoattractant effect 
(221). CCL2 binds to CCR2 receptors of myeloid cells, inducing chemotaxis and it is known to be 
essential for recruitment of monocytes and for bone marrow monocyte haematopoiesis (222). 
Furthermore, CCL2 also exhibits specific effects on stromal cells: it has been associated with 
promoting angiogenesis and arteriogenesis in endothelial cells (223), and modulating fibroblast 
phenotype and activity by increasing collagen expression and by regulating MMP synthesis (224). 
Interestingly, in CCL2 deficient mice, infarcts have delayed and decreased monocyte infiltration 
and decreased myofibroblast accumulation, while angiogenesis appeared unaffected, highlighting 
that the effect of CCL2 in endothelial cells remains elusive (225). Whether CCL2 has the capacity 
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to induce EndMT is a matter worth of further investigation, given the already known effects in 
endothelial cells and fibroblasts.
In addition, CCL2 has been recently linked with its polarisation modulating effect in GM and M-
BMDMs (203,204). In the study, it was found that CCL2 and its receptor CCR2 determine the 
extent of macrophage polarisation, showing that CCL2 enhances IL-10 production and CCL2 
blockage enhances pro-inflammatory polarisation, while impairing expression of M2-like associated 
markers. These findings are consistent with our data that CCL2 expression in macrophages is 
induced by MCEC while repressing TNF-α and MHCII (Figure 3.23). Further work focusing in 
accurate detection of protein secretion of inflammatory or anti-inflammatory proteins by 
macrophages upon contact with endothelial cells has to be done in order to better understand the 
significance of macrophage biology in the context of EndMT.  
4.4 Conclusion and future perspectives
In conclusion, the findings of this study show that macrophages indeed have a role in inducing 
EndMT. It was shown that in vitro bone marrow-derived, peritoneal-derived and immortalised RAW 
264.7 macrophages all directly induce EndMT via cell-to-cell contact. It was shown that via a 
juxtacrine contact pro-inflammatory LPS-stimulated macrophages are stronger inducers of EndMT 
than non-inflammatory control macrophages. This induction was associated with induction of 
juxtacrine intercellular signalling Notch pathway. However, critical experiments need to be 
performed in order to demonstrate causality between macrophage induced-EndMT and 
macrophage-induced Notch signalling pathway. Mechanistic studies involving blocking and 
silencing of Notch pathway in endothelial cells are promising strategies to evaluate the direct 
contribution of Notch signalling to macrophage induced-EndMT.
Additionally, in this study it was shown that EndMT cells hindered macrophage activation via a 
paracrine and juxtacrine manner. Macrophage’s immense dynamism to respond to their 
environment is therefore reflected in our experiments using endothelial and EndMT supernatants 
on RAW 264.7 cells. Indeed, endothelial cells undergoing EndMT and their environment had an 
impact on macrophage polarisation phenotype. However, the direction and putative function of 
macrophage change of phenotype is not clear, as some fibrotic and alternative activated markers 
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were inhibited. Future work in this direction should put emphasis on clarifying the phenotype that 
macrophages acquire when encountering an EndMT cell. Macrophages adopt different responses 
when encountering apoptotic versus necrotic endothelial cells, and EndMT is associated with high 
levels of apoptosis. It is thus likely that EndMT contributes to a distinct phenotype via apoptotic 
endothelial cells. mRNA array profiling or RNA sequence arrays are suitable strategies to delineate 
differential macrophage RNA expression on the impact of EndMT. 
 This study supports the growing notion that macrophages are highly plastic cells involved in a 
smorgasbord of activities in the healthy and injured organism. In the fibrotic heart, macrophages 
are involved in modulating inflammation, promoting fibrosis and regulating the resolution of the 
fibrotic process (137,140). The addition of modulating EndMT to this spectrum of activities is of 
timely relevance, however further subsequent investigation is now mandatory to elucidate accurate 
specific cardiac macrophage phenotypes in the healing and fibrotic heart and their contribution to 
differential functions. Cardiac macrophage heterogeneity is a growing field which is particularly 
interesting in this context because of the potential clinical perspectives. Considering the extreme 
difficulties with which investigators were confronted when targeting specific cytokines in failed 
clinical trials (114,158,159) it seems more plausible to target specific macrophage populations as a 
therapeutic strategy to modulate inflammatory and pro-fibrotic responses. For these reasons, the 
next steps into elucidating macrophage-induced EndMT must be in the direction of analysing 











ns Supplementary Figure 1. Conditioned 
medium (CM) derived from resident 
peritoneal macrophages does not induce 
EndMT. qRT-PCR showing expression of 
Snail, Slug, Twist, Acta2, and Col1a1 EndMT 
marker genes in MCECs treated with TGF-ß1, 
CM, or both combined. Data is presented as 
means + SEM of three independent 
experiments. ns = not significant, as 
calculates using non parametric t-test 
between TGF-ß 1 treated samples and CM 
and TGF-ß 1 combined. 
Supplementary data
2. CM derived from Thioglycollate-elicited , but not resident peritoneal 
macrophages, induced EndMT when combined with TGF-ß 1
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Supplementary Figure 2. Conditioned medium (CM) derived from Thioglycollate elicited 
peritoneal macrophages promote EndMT.  qRT-PCR showing expression of EndMT marker 
genes in MCECs treated with TGF-ß1, CM, or both combined. P values show means + SEM 
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